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Abstract 
Quantum dots (QDs) are semiconductor nanoparticles that exhibit size-dependent optical 
properties. Compared to other common fluorophores such as dyes and fluorescent proteins, 
QDs possess higher photon emission rates. Additionally, they have broad absorption 
spectra and narrow, size-tunable emission spectra that enable color multiplexing. Their 
resistance to photobleaching also makes them suitable for tracking over long periods of 
time. Thus, QDs possess numerous properties that make them attractive for biosensing 
applications. However, several concerns must be addressed for their widespread 
implementation in sensing applications. For instance, the most common QDs contain 
cadmium, raising concerns of toxicity. Additionally, several groups anecdotally report 
decreases in fluorescence intensity during QD processing. The research described in this 
document explores several aspects of these difficulties, including a toxicity 
characterization of QDs made of alternative nontoxic materials with various surface 
chemistries. Further, a systematic analysis of QD colloidal stability and fluorescence loss 
during common processing steps such as dilution, centrifugal filtration, and buffer 
exchange is discussed. After addressing these difficulties, the utility of QDs are 
demonstrated in a novel magneto-fluorescent detection and separation platform used on 
protein and DNA analytes. Finally, the development of novel QD-DNA conjugates and the 
wide-reaching potential applications of these QD-DNA conjugates are discussed. 
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Chapter 1. Introduction 
This chapter presents a brief overview of quantum dots, their properties, and the steps 
needed to prepare them for biological applications. 
 
Quantum Dots – Size Dependent Properties 
Quantum dots (QDs) are semiconductor nanoparticles with sizes typically on the order of 
1-20 nm.1 Upon excitation with ultraviolet light, QDs exhibit a size-dependent fluorescence 
emission, giving them broad utility in sensing applications. As photon absorption occurs, 
electrons are excited from the valence band to the conduction band, resulting in the 
formation of an exciton. The recombination of this electron-hole pair can result in energy 
release in the form of fluorescence.2 
The size dependence of QD emission is a result of the electronic energy band spacing. 
Starting with a single atom, electrons occupy atomic orbitals of discrete energy levels. In 
a nanocluster, where several atoms interact with each other, atomic orbitals split into 
molecular orbitals that must have different energies according to the Pauli exclusion 
principle. When enough atoms are interacting as part of a solid, the density of states forms 
a continuous band, characteristic of bulk materials (Figure 1). Lying at an intermediate size 
range are nano-sized solids, which have quantized bands that cause them to exhibit 
behaviors characteristic of both atomic and bulk materials. These bands are centered 
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around atomic energy levels and first develop in the center, with edges developing last.3 
For semiconductors, where the Fermi level lies between the valence and conduction bands, 
the band edges dominate electronic energy transitions. Therefore, electronic and optical 
properties are strongly dependent on the size (number of atoms) of the cluster, as atoms in 
larger clusters have stronger nearest neighbor interactions that increase the width of the 
bands.3 
 
 
Figure 1 (a) Interaction energy between two atoms as a function of separation distance. (b) 
As the number of atoms in a cluster increases, the energy states develop into continuous 
bands. Figure reproduced from Owens and Poole 2008.4 
 
Quantum confinement effects, which occur when the size of a QD is less than the Bohr 
diameter, result in the oscillator strength (transition probability) being concentrated into 
just a few transitions. Additionally, quantum confinement effects yield higher energy 
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electronic transitions.3 Higher energy transitions for quantum confined systems can be 
explained by the increased binding energy of electron-hole pairs. In a confined system, the 
exciton size is limited by the QD size. This means that the electron-hole pair is squeezed, 
resulting in a higher coulombic attraction force.5 Bandgap widening can be seen using an 
approximation where a quantum dot can be considered as a box with zero potential inside 
the box and infinite potential outside the box (particle in a box). The energy spectrum is 
then given by Equation 1.1 
𝐸𝑛1,𝑛2,𝑛3 =
ħ2𝜋2
2𝑚𝑒
∗ (
𝑛1
2
𝑎𝑥
2 +
𝑛2
2
𝑎𝑦
2 +
𝑛3
2
𝑎𝑧
2) , 𝑛1, 𝑛2, 𝑛3 = 1,2,3, …  Equation 1.1 
Where 𝑎𝑥, 𝑎𝑦, 𝑎𝑧 are the dimensions of the box.
5 Evidently, bandgap widening is observed 
with decreasing particle size. 
Quantum Dot Synthesis 
For application in biological systems, QDs must be water soluble. The first established QD 
synthesis methods were entirely aqueous, where salts of the QD components are simply 
mixed together in the presence of a capping ligand.6  This is known as the arrested 
precipitation method. The advantages of this method are that the QDs are already in 
aqueous phase, and the simplicity of this method lends itself to scalability. However, this 
method yields highly polydisperse particles with many defects, resulting in poor optical 
properties (i.e., low quantum yield, broad emission spectra). Today, the most common 
approach for QD synthesis is known as high temperature precursor decomposition. In this 
approach, organometallic precursors are heated until they decompose into reactive ions. 
The precursors are all added together at once with a coordinating ligand, resulting in an 
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instantaneous nucleation followed by growth via controlled Ostwald ripening. This 
instantaneous nucleation yields a monodisperse population of nanoparticles with a narrow 
emission bandwidth.7 However, QDs prepared via high temperature precursor 
decomposition must undergo subsequent surface modifications for aqueous phase transfer 
if biological applications are desired. 
CdSe group II-VI QDs are the most common QD core material. However, CdSe 
nanoparticles alone have low quantum yields (~10%).2 To overcome this, different capping 
materials can be grown as a shell around the core to form a core-shell structure.8 The 
synthesis of the shell is similar to the core synthesis, where organometallic precursors are 
injected at a high temperature and grown over top of the cores. If the shell material is a 
semiconductor with a wider bandgap than the core material (classified as a type-I core-
shell structure), enhancement of optical properties is observed. For example, with 
CdSe/ZnS QDs, quantum yield increases to about 40-50% compared to CdSe alone.2 In 
this type of structure, the electrons and holes are confined in the core, and the shell serves 
to passivate the surface of the core. One effect of the shell is to physically separate the core 
of the QD (where radiative excitonic recombination is occurring) from the surrounding 
environment, minimizing interactions such as oxidation that can be detrimental to the 
optical properties. Additionally, trap states resulting from surface defects and dangling 
bonds at the surface of the core are reduced, improving quantum yield. Besides quantum 
yield, other optical properties of the QDs are not significantly changed. Typically, a red 
shift of about 5-10 nm in the absorbance and emission peaks is observed.9 
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There are a few other important considerations for synthesizing core-shell QDs. For 
example, when choosing shell materials, the core and shell must crystallize in the same 
structure but have a small lattice mismatch for epitaxial growth to occur. Additionally, the 
thickness of the shell must be well controlled. A shell that is too thin does not passivate the 
surface well. However, a shell that is too thick can generate trap states because of lattice 
strain resulting from the lattice mismatch with the core.9 
Post-Synthesis Modifications of Quantum Dots 
As mentioned previously, the highest quality QDs are synthesized in organic phase. Thus, 
one of the first steps in developing QD biosensors is to modify the surface chemistry of the 
QDs to make them water soluble. There are three common strategies to do this.10 In one 
method, known as ligand exchange, the original hydrophobic ligand is substituted with a 
higher affinity ligand containing a hydrophilic end group that faces outward from the 
particle. Thiol ligands are commonly used for this strategy.11 In another approach, a silica 
shell is grown on top of the QD and the surface can be subsequently modified for different 
applications.12 The last general method for QD water solubilization is polymer 
encapsulation, where QDs are either encapsulated in micelles or hydrophobic polymers 
derivatized with hydrophilic groups interdigitate with the original QD ligand.13 
Following aqueous phase transfer, QD surface chemistry is often further modified to enable 
targeting to specific analytes. Although the specific surface modification varies widely 
depending on the desired application, several common general conjugation schemes are 
typically employed. In some cases, electrostatic adsorption of proteins to charged QD 
surfaces has been used for surface modification.14 In many other cases, however, 
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biomolecules are covalently linked to QDs using bioconjugation chemistries. For example, 
carbodiimide crosslinker chemistry crosslinks carboxylic acids and primary amines to form 
amide bonds. This approach, although low yielding (<30%), is frequently used for antibody 
and other protein conjugation schemes. Other common functional groups used in 
crosslinking include amine-reactive N-hydroxysuccinimide ester groups and sulfhydryl-
reactive maleimide groups.15 More recently, copper-free click chemistry has been used in 
QD bioconjugation methods because of its high yields (~67%) and reaction specificity.13 
However, click chemistry functional groups typically must first be conjugated via 
previously mentioned approaches. Even so, reaction yields are often higher in the multi-
step click chemistry approach because the small molecules containing click chemistry 
functional groups are easier to conjugate than larger protein and DNA molecules. 
Motivation – QDs in Biosensing Applications 
Overall, QDs exhibit a number of useful optical properties for sensing applications that are 
unique from other fluorophores such as organic dyes and fluorescent proteins. For instance, 
they have much higher absorbance cross sections, enabling higher photon emission rates 
that can improve signal-to-noise ratio. The broad absorption spectra and narrow, tunable 
emission spectra of QDs lend them to multiplexing, as several QDs with distinguishable 
emission wavelengths can be simultaneously excited with the same wavelength. 
Additionally, QDs are stable against photobleaching, making them useful for real-time 
monitoring of processes that occur over longer timescales.13  
However, several difficulties remain that limit the potential applications of QDs. For 
example, the most well-studied QDs are cadmium based, and cadmium ions are known to 
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have several toxic effects in biological systems.16 In Chapter 2, QDs synthesized from 
nontoxic alternative materials are discussed, with a focus on toxicity characterization. 
Next, in Chapter 3, the difficulties of QD fluorescence loss during common preparation 
steps for biological applications is discussed, using data from QDs of several different 
vendors to highlight the universality of these problems. In Chapter 4, methods of QD 
sensing are discussed, and a magneto-fluorescent detection and separation platform for 
DNA and protein analytes is described. Finally, Chapter 5 describes a conjugation scheme 
for compact QD-DNA systems with applications in sensing based on fluorescence 
resonance energy transfer. Conclusions and the future directions building off the work from 
Chapter 5 are discussed in Chapter 6. 
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Chapter 2. Toxicity Assessment of Micelle encapsulated Mn-doped ZnSe Quantum dots 
This chapter describes the preparation of nontoxic aqueous quantum dots and analysis of 
their toxicity using a human liver cancer cell line. This study was funded by NSF DBI-
1555470. The Mn-doped-ZnSe synthesis and surface modifications were done by Dr. Qirui 
Fan, Dr. Abhilasha Dehankar, and Thomas Porter. The toxicity studies on CdSe/ZnS-MPA, 
CdSe/ZnS micelles and Mn-doped-ZnSe-MPA were conducted by Dr. Qirui Fan. The 
toxicity studies on Mn-doped-ZnSe micelles and TUNEL assay on Mn-doped-ZnSe-MPA 
were conducted by Dr. Abhilasha Dehankar and Thomas Porter. TEM imaging of the 
particles was conducted by Dr. Abhilasha Dehankar. The statistical analysis of the toxicity 
results was conducted by Dr. Abhilasha Dehankar and Thomas Porter. The first draft of 
this chapter was authored by Dr. Qirui Fan. The materials and method section and images 
for the paper were prepared by Thomas Porter and Dr. Abhilasha Dehankar. The final draft 
for this chapter was edited by Dr. Abhilasha Dehankar. 
Introduction 
Semiconductor nanocrystals, or quantum dots (QDs), have attracted growing interest over 
the past two decades. QDs have been used in solar cells, LEDs, lasers, bioimaging, 
biosensors, and therapeutics.17–20 Further, QDs are known to possess exceptional 
brightness, sharp emission peaks, large stokes shifts, and extraordinary photostability in 
contrast to their traditional fluorescent counterparts – molecular dyes.21 As a result, QDs 
present themselves as ideal replacements for low-performing molecular dyes. However, 
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conventional QDs are synthesized from heavy metal elements such as cadmium, raising 
concerns about their toxicity both in biological systems and in the environment.22,23 
As early as 2004, Derfus et al. correlated QDs toxicity with the release of Cd2+ in vitro24, 
and Hoshino et al. first discovered the critical role of QDs surface coating in cytotoxicity25. 
Since then, numerous investigations have been conducted to elucidate the toxicity 
mechanisms of QDs and to develop strategies toward reducing their toxicity.22,26–28 
Although some of these studies report different or contradicting results, likely because of 
the varying QDs preparation processes and the complexity of the biological systems (i.e., 
various cell types29, cell culture vs. animals27), most of them attribute QDs toxicity to the 
constituent elements and physicochemical properties, such as surface charge, ligand length, 
and size of the nanoparticles30. Therefore, for a comprehensive understanding of QDs 
toxicity, studying the effects of both NP constituents and physicochemical properties is 
necessary. 
Primarily, the constituent elements (e.g., cadmium) can be extremely toxic and detrimental 
to various organs. On a cellular level, cadmium causes DNA damage, induces an elevated 
level of reactive oxygen species (ROS) that leads to apoptosis, and affects other biological 
activities.31 Although a layer of ZnS shell can reduce the toxicity of the CdSe QDs23,24, 
QDs toxicity is more complex than the mere presence of the cadmium element32. 
Cadmium-free QDs are preferred both for reduced cytotoxicity and for the environment in 
the long run.33,34 For example, indium phosphide provides an alternative elemental 
composition for QDs covering the visible wavelength range, and the InP/ZnS core/shell 
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QDs have shown reduced toxicity.35,36 Further, QDs of ZnSe or ZnS nanocrystals doped 
with manganese (Mn) have also demonstrated decreased toxic effects.37–43  
The physicochemical properties of QDs synthesized in the organic phase are primarily 
determined by their phase transfer method (e.g., ligand exchange, micelle encapsulation, 
or silica coating) and materials (e.g., ligands, coating). Mainly, different coating strategies 
produce QDs of different sizes and surface chemistries that not only have a direct impact 
on toxicity but also affect the cellular uptake of nanoparticles and their subsequent 
subcellular distribution.30,44–47 Generally, charge produces more dominant effects as 
compared to ligand length and particle size30, but in animal studies, size may become a 
critical factor because of the renal clearance threshold48. 
Recently, we reported the synthesis of Mn-doped ZnSe QDs that are believed to possess 
more promising super-resolution imaging and magnetic resonance imaging (MRI) features 
than conventional QDs.49 These doped QDs displayed a novel tetrapod shape, unlike most 
spherical shaped Mn-doped QDs that have demonstrated lower toxicity.38,39,43 To our 
knowledge, none of the toxicity studies on Mn-doped QDs in the literature were conducted 
on tetrapod shaped nanocrystals.38–43 Thus, the interaction and toxicity effects of irregularly 
shaped cadmium-free nanocrystals on cells were unclear before this study. Also, in the 
same study, we showed enhanced brightness and photostability of individual assemblies of 
micelle templated CdSe/ZnS QDs and Mn-doped ZnSe QDs against high-intensity laser 
radiation desirable for super-resolution imaging.49 The observed results were attributed to 
the thicker layer of micellar protection that limited the diffusion of any oxidative species. 
Thus, micelles prove to be a better barrier compared to conventional ligands. Therefore, 
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current work presents the first in-depth toxicity analysis of the tetrapod-shaped Mn-doped 
ZnSe QDs phase-transferred to aqueous phase by micelle encapsulation. 
Here, we compared the toxicity effects of our cadmium-free Mn-doped ZnSe QDs on 
HepG2 human liver carcinoma cell lines with that of commercial CdSe/ZnS core/shell 
QDs. Additionally, we evaluated these QDs at different physicochemical property 
conditions, size, and material by studying their toxicity response after aqueous transfer by 
ligand exchange versus micelle encapsulation. Assays elucidating cell viability and 
proliferation, ROS generation, and DNA fragmentation were performed considering the 
commonly observed toxicity pathway for cadmium-based QDs at different concentrations 
of QDs. Our results show that Mn-doped ZnSe QDs display negligible toxicity and micelle-
encapsulation eliminates the toxicity of CdSe/ZnS QDs in the studied concentration range. 
Material and Methods 
Materials 
Zinc stearate (12.5-14%, ZnO), selenium powder (99.999%, ~200 mesh), 
tetramethylammonium hydroxide pentahydrate (TMAH, 25% w/w in methanol), 
manganese chloride (MnCl2, 97%), and octadecylamine (ODA, 98%) were purchased from 
Alfa Aesar. Stearic acid (SA, ≥98.5%), 1-octadecene (ODE, ≥95.0%), 3-
mercaptopropionic acid (MPA, ≥99%), and tributyl phosphine (TBP, 97%), acetone 
(≥99.9%), and poly(vinyl alcohol) (PVA , 13-23 kDa, 87-89% hydrolyzed) were 
purchased from Sigma-Aldrich. Chloroform was purchased from Fisher Scientific. 
Poly(styrene-b-ethylene glycol) (PS-PEG-COOH) with a carboxylic acid termination 
(molecular weight of 18-b-9.5 kDa) was purchased from Polymer Source. Organic 
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CdSe/ZnS QDs (λem = 605 nm) dispersed in decane and CdSe/ZnS QDs with carboxylic 
acid termination (λem = 605 nm) dispersed in pH 9 borate buffer were purchased from 
Invitrogen. 
Preparation of Mn-ZnSe QDs 
Mn-doped ZnSe QDs were synthesized using the following protocol described by Pradhan, 
N., et al.50,51 
Synthesis of MnSt2 precursor 
 
Briefly, SA (1.42 g) was dissolved in methanol (10 mL) in a three-neck flask (100 mL) by 
heating (~50-60 °C) until the solution became transparent. Then, the solution was cooled 
to room temperature, resulting in the formation of white SA precipitates. Next, 2.3 mL of 
TMAH diluted with 1.5 mL of methanol was added dropwise to the SA precipitates until 
their complete dissolution. Then, MnCl2 (0.315 g) dissolved in methanol (3.15 mL) was 
added dropwise to the transparent solution above under vigorous stirring, producing white 
precipitates of MnSt2. The MnSt2 precipitate was washed six times with methanol to 
remove unreacted precursors and dried under vacuum before the synthesis of Mn-doped 
ZnSe QDs.  
Synthesis of Mn-doped ZnSe QDs  
 
In a typical experiment, a Se-TBP stock solution was prepared inside a glove box by 
dissolving Se (0.63 g) in TBP (2.7 mL). Then, the Se-TBP stock solution (1.5 mL) was 
injected in a 25 mL three-neck flask containing ODA (1.3 g) inside the glove box and 
immediately connected to an inert argon (Ar) manifold after removal from the glovebox. 
The mixture was then heated to ~70˚C under Ar to dissolve the ODA. Next, MnSt2 (0.1g) 
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and ODE (25 mL) was loaded into a 100 mL three-neck reaction flask. The reaction 
solution was then heated to 110°C until the solution turned transparent, followed by Ar 
bubbling at 110°C for 20 minutes. Later, the reaction solution was gradually heated to 
290°C under Ar. At 280°C, the entire Se-TBP stock solution was swiftly injected into the 
reaction solution. After the injection, the reaction temperature was reduced to 260°C for 
60 minutes.  
Meanwhile, ZnSt2 stock solution was prepared by mixing ZnSt2 (2.5 g), SA (0.5 g), and 
ODE (12 mL) in a 50 mL flask, followed by heating to ~150°C and degassing under argon. 
Additionally, ODA-ODE solution was prepared by mixing 2.5g of ODA and 2.5 mL of 
ODE in a 15 mL flask. After 60 minutes, the reaction temperature was set to 300°C, and 
the heated ZnSt2 stock solution (4 mL) was swiftly injected into the reaction solution at 
290°C. The reaction temperature was then reduced to 260°C, followed by addition of 
melted ODA-ODE (1 mL) solution. Next, the ZnSt2 stock solution (3 mL per injection) 
was injected in 15 minute intervals for three injections. Additionally, melted ODA-ODE 
solution (1 mL) was injected 5 minutes after each ZnSt2 injection. The reaction solution 
was cooled to room temperature 15 minutes after the final ZnSt2 injection. The unpurified 
Mn-ZnSe nanocrystals were stored at 4°C. 
Purification of Mn-ZnSe QDs 
 
Mn-doped-ZnSe QDs were purified immediately before ligand exchange or micelle 
encapsulation by employing anti-solvent precipitation. During purification, 100 µL 
chloroform was added to unpurified QDs heated to 37°C (100 µL) and the mixture was 
heated to 70°C. Following this, acetone (200 µL) was added to the transparent solution and 
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the mixture was re-heated to 70°C. The QDs were then centrifuged (20817 rcf, 20 seconds) 
out of the solution. After removal of the supernatant, the same procedure was repeated two 
more times, and the final QD pellet was dissolved in chloroform. 
Preparation of water-soluble QDs 
Synthesis of QD-MPA by ligand exchange  
 
Both water-soluble CdSe/ZnS and Mn-ZnSe QDs were produced from their organic 
precursors in chloroform via ligand exchange with 3-mercaptopropionic acid (MPA). 
Organic CdSe/ZnS QDs in decane were first transferred to chloroform using a 
methanol/isopropanol mixture (2/1 v/v) to precipitate the QDs. For ligand exchange, QDs 
dissolved in chloroform (300 µL) were mixed with MPA (30 µL) and sonicated for 1 hour. 
After 1 hour, the solution was centrifuged, and the pellet was washed once in chloroform. 
Next, the pellet was dissolved in 10 mM NaOH, followed by purification of excess MPA 
by centrifugal filtration (100 kDa, three times) and recovery. Both the QDs-MPA were 
sterilized by passing them through a 0.22 µm syringe filter before resuspension in cell 
medium at the desired concentration. 
Synthesis of micelle encapsulated QDs 
 
Micelles encapsulating QD nanoparticles were created using the interfacial instability 
process. For micelle encapsulation of CdSe/ZnS QDs, QDs (0.35 mg/mL, 100 µL) and PS-
PEG-COOH (20 mg/mL, 10 µL) in chloroform were mixed together in a 15 mL centrifuge 
tube, followed by addition of PVA (5 mg/mL, 3 mL) dissolved in water to form an 
emulsion. The emulsion was then bath sonicated for an hour to achieve uniform emulsion 
droplets. The chloroform in the emulsion was subsequently evaporated over time in an 
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aluminum dish on a rocker, forming micelle-encapsulated QDs in the aqueous solution. 
Empty micelles were prepared by the same procedure using chloroform (100 µL) devoid 
of QDs. For Mn-doped-ZnSe QDs, first, the native ligand was exchanged with octanethiol 
by employing the procedure used for MPA ligand exchange. The QDs were subsequently 
washed twice with an acetone/methanol mixture (60/40 v/v 1st wash, 50/50 v/v 2nd wash) 
to remove excess octanethiol. For micelle encapsulation of Mn-ZnSe QDs, QDs (1.3 
mg/mL, 50 µL) and PS-PEG-COOH (20 mg/mL, 10 µL) in chloroform were mixed in a 10 
mL glass vial, followed by addition of PVA (5 mg/mL, 3 mL) dissolved in water. The 
mixture was then probe sonicated for 2 mins, and the chloroform in the resulting emulsion 
was evaporated over time in an aluminum dish on a rocker to form a clear solution of 
micelle encapsulated QDs. Both the micelles encapsulated QDs were sterilized by passing 
them through a 0.22 µm syringe filter. The sterilized micelles encapsulated QDs were then 
washed five times using a 100 kDa centrifugal filter to remove excess PVA before 
resuspension in cell medium at the desired concentrations. 
Toxicity assays 
HepG2 cells were used to evaluate QD toxicity in vitro. Cells were cultivated in improved 
minimum essential medium (MEM) with 10% FBS, 1% penicillin/streptomycin (10k 
U/mL), and 0.2% mycozap at 37°C, 5% CO2. Cells were fed every other day and passaged 
at ~ 80% confluency. 
MTT assay  
 
MTT tests were performed with the Vybrant® MTT Cell Proliferation Assay Kit (V-13154, 
Life Technology). Briefly, cells were seeded in 96 well plates at 5,000 cells per well with 
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five replicas at each concentration level. As prepared nanoparticle samples were diluted to 
experimental concentration with concentrated cell medium. After 24 h incubation, cell 
medium was removed, and 50 µL of nanoparticle solution was added to the plate and 
incubated with the cells for 24 h. Then, the nanoparticles were removed, and 100 µL of 
phenol red-free cell medium and 10 µL of 12 mM MTT solution was added to each sample 
and control well in the plate and incubated for four hours. Finally, 10% SDS solution was 
added to the plate to dissolve the formazan (converted from MTT by viable cells), and the 
product was evaluated at 570 nm using a microplate reader. 
ROS assay  
The ROS assay was performed with CellROX® Green Reagent (C10444, Life 
Technologies). Cell culture and nanoparticle incubation were identical to the MTT assay, 
except the cell seeding density of 20,000 cells/well. The stock ROS reactive dye solution 
was added to the cell medium at a final concentration of 12.5 µM. The dye was incubated 
for 30 min before washing with PBS twice. Then, the plate was measured using a 
fluorescent microplate reader under the FITC filter setting. 
TUNEL assay  
The apoptosis study was performed using the Click-iT® Plus TUNEL kit, employing Alexa 
Fluor® 488 (C10617, Life Technologies) kit. Cell culture and nanoparticle incubation were 
as described in the ROS assay (3 replicas at each QD concentration), and stock solutions 
were prepared according to the manufacturer’s instructions. After treating cells with 
nanoparticles for 24 h, the cells were washed with PBS, fixed with paraformaldehyde, 
permeabilized with Triton X-100. Treatment for one hour with 10 unit/mL of DNase (Life 
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Technologies, 18068-015) was used as a positive control. Cells were then treated with 
EdUTP nucleotide mixture and TdT (terminal deoxynucleotidyl transferase), labeled with 
Alexa 488 through copper (I) catalyzed click chemistry, and measured using a fluorescent 
microplate reader under the FITC filter setting. 
Statistical Analysis 
One-way ANOVA was used to determine statistically different assay readouts among 
different concentrations of the same type of QDs, with p<0.05. If the mean readouts were 
found to be statistically different, a Dunnett’s test was conducted to compare each sample 
to its control, with p<0.05. For MTT and ROS assays, three replicate plates with five 
repeats of each concentration and controls were measured per plate. ROS consisted of two 
controls – a positive and negative control, whereas MTT consisted of only one negative 
control. Within each plate, the five repeat measurements per concentration or control were 
averaged. The average readouts of blank wells were then subtracted from the average of 
sample and control wells to determine the absolute measurement of each concentration and 
control, respectively. Next, within each plate, the calculated absolute readouts were 
normalized against the absolute control value. Statistical tests were conducted on these 
normalized values from each plate. Standard deviations were calculated and normalized 
within each plate from the five replicate measurements, and then a pooled standard 
variance was determined from the three plates for concentration/control. For the TUNEL 
assay, only one plate with three replicate measurements of each concentration, a positive 
control, and a negative control was measured.  Readouts from blank wells were subtracted 
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from the sample measurements, and statistical tests were conducted on the three replicate 
values of each sample. The final values were then normalized to the averaged control value. 
Results and Discussion 
Selection of commercial QDs for toxicity analysis 
One of the primary goals of this investigation was to evaluate the effectiveness of micelle 
templates compared to conventional surface ligands on CdSe/ZnS QDs. However, it is 
evident from the literature that different CdSe/ZnS QDs may possess different toxicity 
depending on their size and surface ligands.30 Thus, it was essential to choose the 
CdSe/ZnS QDs that are capable of producing a significant difference in toxicity signal in 
a limited amount of time for the study. Therefore, we first performed a primary response 
screening of diverse sizes of commercial CdSe/ZnS QDs from different vendors at different 
concentrations to identify the most toxic QDs. For this study, we performed an MTT assay 
to measure the viabilities of cells treated with different sized aqueous QDs from two 
different vendors (QD560, QD580, QD600 from vendor 1 and QD605 from vendor 2) at 
two different concentrations. Results showed lower cell viability in vendor 2 QDs as 
compared to vendor 1 QDs even at higher concentrations (Figure 2). Assessing the origin 
of these differences was beyond the scope of this investigation. Regardless, vendor 2 
QD605 displayed the highest potential to serve as the control CdSe/ZnS QDs for observing 
coating-based toxicity differences and were selected for detailed toxicity analysis. 
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Figure 2 MTT test of different types of CdSe/ZnS QDs (QD560, QD580, QD600 are from 
Vendor 1, at 40 μg/ml and 200 μg/ml, respectively; and QD605 is from Vendor 2, at 20 
μg/ml and 100 μg/ml, respectively). QDs with an asterisk show statistically significant 
differences in cell viabilities at different concentrations 
 
Characterization of phase-transferred Mn-doped ZnSe QDs 
Mn-doped ZnSe QDs were synthesized in-house by a nucleation-doping strategy 
introduced by Pradhan. et. al. in the organic phase.50 The resulting Mn-doped ZnSe QDs 
displayed an absorption shoulder at ~440 nm and an emission peak at 575 nm.49 Notably, 
the Mn-doped QDs produced are tetrapod-shaped, in contrast to spheres or elongated rods. 
Despite their poor performance evident from the decreased colloidal stability, fluorescence 
preservation, and high non-specific binding observed in MPA-coated QDs, MPA ligands 
have been the most commonly used ligands in the toxicity study literature.23–25,32,47 
Additionally, PEO (or PEG) in PS-PEG-COOH is known for reducing non-specific 
interaction with proteins, and negative surface charges such as carboxylic acid (-COOH) 
have demonstrated lower toxicity than positively charged NPs.30 Therefore, Mn-doped 
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ZnSe (Figure 3) and CdSe/ZnS QDs were transferred to the aqueous phase either by ligand 
exchange with MPA for comparison with existing literature or via micelle encapsulation 
with amphiphilic polymer, PS-PEG-COOH. 
 
 
Figure 3 MPA coated Mn-ZnSe QDs (Mn-ZnSe-MPA, left), Micelle encapsulated Mn-
ZnSe QDs (Mn-ZnSe-Micelle, right) 
 
Before advancing toward in-depth toxicity analysis, preliminary studies described below 
were conducted to account for the toxicity effects from the constituent materials involved 
in micelle encapsulation. Micelle formation via interfacial instability employed in the 
current study involves the dissolution of QDs and polymers in chloroform during the 
encapsulation process. However, Chloroform is highly toxic. As a result, it is necessary to 
confirm that chloroform in the final composite is below the acceptable limit for biological 
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application despite its volatility and low miscibility (8.09 g/L at 20°C) in water. A 
quantitative colorimetric assay (data not shown) was applied to determine the final 
chloroform concentration in the solution used for treating the cells.52 Results indicate the 
presence of < 5.7 ppm chloroform, which is considerably below the permissible 
occupational exposure limit of 50 ppm according to the Occupational Safety and Health 
Administration. 
Additionally, PVA was used during micelle preparation as an emulsifier. MTT assay was 
conducted on cells exposed to varying concentrations of PVA to account for toxicity effects 
of PVA present in the micelle dispersions after purification. No significant changes were 
observed in cell viabilities after PVA treatment, indicating negligible cytotoxicity (Figure 
22). Similarly, the toxicity effects of empty micelles were investigated by treating the cells 
at varying concentrations of micelles prepared in the absence of QDs. MTT assay showed 
no reduction in cell viabilities after treatment with empty micelles, suggesting insignificant 
toxicity effects (Figure 23). 
As mentioned in our previous work, the micelle templated QDs have sizes ranging from 
30-50 nm.49 However, larger nanoparticles possess a high tendency toward aggregation. 
Although our QD micelles displayed good stability in normal conditions, signs of 
aggregation appeared after concentrating them by high-speed centrifugation (e.g., 20k rcf) 
or centrifugal filtration (using 100kDa filters). Concentrations of QD-micelles are 
frequently increased during toxicity studies to achieve desired concentrations for treating 
cells. For example, CdSe/ZnS micelles were first concentrated to 250 µg/mL by centrifugal 
filtration and then diluted into the cell medium at the desired concentration for toxicity 
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studies. MTT assay was performed on cells treated by different concentrations of 
CdSe/ZnS micelles by dilution from 250 µg/mL versus 35.0 µg/ml. To account for the 
effect of toxicity because of over-concentration. MTT results for dilution from 250 µg/mL 
showed a cell viability of 90% at 12.5 µg/mL, and 53% at 25.0 µg/mL (Figure 24) whereas 
negligible toxicity was observed in QD-micelles diluted from 35.0 µg/ml (Figure 4). 
Observed toxicity for treatment by diluting highly concentrated micelles may be attributed 
to deformations in the QD or micelle structures during the aggregation promoting the 
leakage of the toxic elements of CdSe/ZnS QDs into the cellular solution. Therefore, all 
micelle solutions were prepared at 35.0 µg/mL solution for the remainder of this study. 
Effect on cell viability and proliferation  
All toxicity studies were conducted on the human hepatic cell line HepG2 cells after 
treating them with MPA or micelle templated QDs for 24 hours. Initially, MTT assays were 
performed on the cells treated with QDs at concentrations ranging from 1.56 - 25.0 µg/mL. 
The effect on cell viability was determined by comparison with the viabilities of untreated 
cells (Figure 4). Results for CdSe/ZnS-MPA QDs displayed a statistically significant 
decrease in the MTT signal at a concentration as low as 3.13 µg/mL. The cell viability 
decreased further with increasing concentration. Additionally, although the average 
viability of the 1.56 µg/mL wells did not show a statistically significant difference as 
compared to untreated cells, the possibility of a negative impact on cells below the 
detection limit of this assay cannot be eliminated. The observed effects on cell viability can 
be correlated to the toxic nature of cadmium ions as evident from previous studies. 
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Although ZnS shell coating can alleviate the release of the cadmium ions, the thickness 
and the quality of the coating may offer varying degrees of protection.23,24 
 
 
Figure 4 MTT assay on 4 types of QDs: CdSe/ZnS-MPA: MPA coated CdSe/ZnS QDs; 
CdSe/ZnS-Micelle: Micelle encapsulated CdSe/ZnS QDs; Mn-ZnSe-MPA: MPA coated 
Mn-doped ZnSe QDs; Mn-ZnSe-Micelle: Micelle encapsulated Mn-doped ZnSe QDs. Cell 
viabilities of QD concentration with different letter show statistically significant difference 
from control. 
 
In contrast, the tetrapod-shaped Mn-doped ZnSe QDs with MPA ligands did not show 
significant cell viability reduction at any of the tested concentrations. The observed results 
were analogous to other investigations that demonstrated minimal toxicity of Mn-doped 
QDs. For example, Drobintseva et al. observed that exposing the human mononuclear 
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lymphocytes to Mn-doped ZnSe QDs did not cause cell morphology change.40 Zhou et al. 
conjugated Mn-doped ZnSe/ZnS QDs with nano-hydroxyapatite (80-120 nm nanorods) 
and did not observe significant toxicity at 200 µg/ml for HepG2 cells (Note: The molar QD 
concentration in this study is probably much lower than our QDs because of the large size 
of the tested nanorods).38 Mohammad et al. synthesized Mn-doped ZnS QDs, and showed 
close to 100% cell viability at a 25 µg/mL particle concentration over a 24 hour incubation 
period, but showed decreased viability for higher concentrations.43 Despite the differences 
in the doped QD compositions and the synthesis routes, these studies suggest lower toxicity 
of Mn-doped QDs over conventional CdSe/ZnSe QDs, complementary to our observations. 
Further, the micelle templated CdSe/ZnS, as well as Mn-doped ZnSe QDs, also showed no 
reduction in cell viability for 24-hour incubation. Micelle encapsulation for aqueous 
transfer of QDs retaining the native surface ligands of QDs offers an additional layer of 
protection. Thus, unlike the ligand exchange process that displaces the native ligands (e.g., 
octadecylamine and trioctylphosphine oxide in our QDs) and promotes the introduction of 
surface defects by stripping of surface cations53,54, micelle encapsulation preserves the 
integrity of the nanocrystals. Also, the thick polymer layer may decrease the rate of 
constituent ions being released out of the micelles over time. Our previous study has shown 
that micelle-templating offers protection against high intensity induced photobleaching of 
QDs.49 Here, the MTT result suggests that micelle protection could also be applied to cell 
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toxicity reduction. These findings are in agreement with Yong et al. that reported 
phospholipid-PEG micelle coated QDs as safe at a dosage as high as 150~200 µg/mL.28 
Lastly, the observed effect on cell viability is cumulative of cellular uptake efficiency and 
particle toxicity. Cellular uptake is dependent on particle size and surface charge.46 Thus, 
the size difference between the micelles (~30-40 nm) and the MPA QDs (<10 nm) may 
affect the efficiency of the endocytosis and exocytosis processes.55 However, cellular 
uptake exhibits a stronger dependence on the surface charge compared to size.46 Since both 
MPA and PS-PEG-COOH display carboxylic acid groups on their surfaces, their cellular 
uptake may be considered to be at comparable levels. Additional analysis of cellular uptake 
is beyond the scope of this investigation. 
Reactive oxygen species formation  
Changes in cell viability is a cumulative effect of changes in the amount and the metabolic 
rates of cells. Thus, negligible changes in cell viability may occasionally be observed 
despite significant changes in the cellular metabolic rates. Changes in metabolic rates have 
often been correlated to the presence of oxidative stress by the generation of ROS.56 
Further, cadmium-based cytotoxicity has also been associated with the generation of 
reactive oxygen species (ROS).31 Therefore, ROS assay was performed on cells treated 
with QDs to further investigate the toxicity of Mn-doped QDs and the mechanism of 
CdSe/ZnS-MPA toxicity. The differences in the generation of ROS after NP treatment were 
determined by comparison with untreated cells (Figure 5). Menadione stimulates the 
production of ROS in cells and was employed as a positive response control. The micelle 
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templated CdSe/ZnS QDs and MPA coated and micelle encapsulated Mn-doped QDs did 
not produce significantly different ROS signal as compared to the untreated cells (alpha = 
0.05, p < 0.05) whereas significantly higher ROS signal was produced in menadione treated 
cells. Thus, results indicate that MPA coated Mn-doped ZnSe and micelle encapsulated 
QDs do not increase the ROS in HepG2 cells. 
Interestingly, ROS signal for the CdSe/ZnS-MPA QDs was also not significantly different 
from menadione treated cells, unlike many different studies that have observed enhanced 
production of ROS in toxic QDs.57,58 However, many other studies also report an obscure 
correlation between ROS generation and QD toxicity. For example, Lovrić et al. observed 
that NAC (N-acetyl-L-cysteine), a ROS inhibitor, could partially reduce QD toxicity, but 
another antioxidant Trolox did not prevent cellular damage.47 In another study, Nagy et al. 
found that pretreating cells with NAC did not rescue cell viability even after lowering ROS 
production.30 Nagy et al. correlated the observed toxicity to up-regulation and down-
regulation of certain genes, suggesting the presence of other toxicity pathways independent 
of ROS production.30 Thus, observed results in our study suggest that CdSe/ZnS-MPA may 
be causing cellular toxicity from a different pathway beyond the extent of the current study. 
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Figure 5 ROS assay on 4 types of QDs: CdSe/ZnS-MPA: MPA coated CdSe/ZnS QDs; 
CdSe/ZnS-Micelle: Micelle encapsulated CdSe/ZnS QDs; Mn-ZnSe-MPA: MPA coated 
Mn-doped ZnSe QDs; Mn-ZnSe-Micelle: Micelle encapsulated Mn-doped ZnSe QDs. 
Normalized ROS signals of QD concentration with different letters show statistically 
significant differences from the control. 
 
DNA fragmentation 
Another factor that indirectly affects cell viability is the number of dead cells. Death of 
cells by toxicity effects is generally associated with an apoptotic pathway and can be 
detected by DNA fragmentation. Further, Cadmium can also damage DNA and replace the 
iron and copper from key cytoplasmic proteins and membrane proteins, in addition to 
generating ROS and causing apoptosis.31 Therefore, TUNEL assay was conducted on QD 
treated cells to detect DNA fragmentation. The differences in DNA breakages was detected 
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by comparing the TUNEL signal of QD treated cells with untreated cells as the control and 
DNase treated cells as the positive control (Figure 6). TUNEL signal of QD treated cells 
was not significantly different from untreated cells, whereas a significant increase was 
observed for DNase treated cells, indicating negligible changes in DNA fragmentation on 
the treatment of HepG2 cells with all the tested QDs. For CdSe/ZnS-MPA QDs, it is 
possible that the release of cadmium ions was enough to impede cell metabolism and 
proliferation, but not enough to produce a detectable DNA fragmentation signal. A 
Live/Dead flow-cytometry assay (L34951, Invitrogen) was performed on the CdSe/ZnS-
MPA QDs treated cells at concentrations of 6.25 ug/mL and 25.0 µg/mL to test this 
possibility. Analysis of the assay results displays an effective decrease in the percentage of 
living cells at 25 µg/mL as compared to 6.25 ug/mL from 82% to 78% with a corresponding 
increase in the number of injured cells (data not shown). Thus, the results of live/dead assay 
support that the decrease observed in cell viability in MTT assay is a consequence of an 
increase in the number of injured cells with lower metabolic activity, which are most likely 
in the preliminary stages leading up to apoptosis. However, further investigations are 
necessary to exactly determine the cell signaling mechanism causing damage to the cell 
membrane after QD treatment. 
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Figure 6 TUNEL assay on 4 types of QDs: CdSe/ZnS-MPA: MPA coated CdSe/ZnS QDs; 
CdSe/ZnS-Micelle: Micelle encapsulated CdSe/ZnS QDs; Mn-ZnSe-MPA: MPA coated 
Mn-doped ZnSe QDs; Mn-ZnSe-Micelle: Micelle encapsulated Mn-doped ZnSe QDs. 
Normalized TUNEL signals of QD concentration with different letter show statistically 
significant difference from control. 
 
Conclusions 
In summary, here we compared the cytotoxicity of the tetrapod-shaped Mn-doped ZnSe 
QDs and conventional CdSe/ZnS QDs, both prepared either through MPA ligand exchange 
or PS-PEO-COOH micelle encapsulation. The Mn-doped ZnSe QDs did not show any 
significant decrease in cell viability or increase in ROS production and DNA fragmentation 
for both types of coatings at the tested concentrations, in contrast to CdSe/ZnS-MPA QDs, 
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suggesting that they are inherently less toxic. Further, micelle-templated CdSe/ZnS QDs 
displayed similar behavior to Mn-doped ZnSe QDs, whereas a concentration-dependent 
decrease in cell viability was observed in CdSe/ZnS-MPA QDs, indicating that micelles 
encapsulation is a better aqueous phase-transfer alternative to ligand-exchange for QDs. 
Therefore, coupled with their excellent optical properties, micelle templated Mn-doped 
ZnSe QDs serve as promising candidates for biological imaging and diagnostic 
applications. 
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Chapter 3. Fluorescence Loss of Commercial Aqueous Quantum Dots during Preparation 
for Bioimaging 
This chapter describes a systematic evaluation of fluorescence loss of quantum dots from 
several common vendors during typical procedures employed during their preparation for 
bioimaging. This study was funded by NSF DBI-1555470. Experimental design and 
fluorescence and absorbance data collection was done by Dr. Kil Ho Lee and Thomas 
Porter. Quantum yield calculations and statistical analysis was conducted by Thomas 
Porter. The introduction was written by Dr. Jessica Winter, the materials and methods was 
written by Thomas Porter, and the remaining sections were written by Dr. Kil Ho Lee. Dr. 
Kil Ho Lee produced the figures. This chapter is published in Lee KH*, Porter T*, Winter 
JO, “Fluorescence Loss of Commercial Aqueous Quantum Dots During Preparation for 
Bioimaging.” MRS Communications, 9(2), 702-709 (2019).59 *Equally contributing 
authors. 
Introduction 
 
The introduction of quantum dots (QDs) for biological imaging in 199812,60 was thought to 
herald a coming revolution in the field. QDs, crystalline semiconductor nanoparticles, 
exhibit many properties conducive to imaging because of their small size. Broad excitation 
spectra enable imaging of multiple colors with a wide variety of excitation sources. High 
absorption cross sections enable improved photon generation compared to molecular 
fluorescent dyes.61 Narrow emission spectra and size-tunable fluorescence are ideal for 
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multiplexed applications that require several distinct colors to be distinguished in the 
visible spectrum. Building on these initial reports, QD labels were demonstrated for in 
vitro62 and in vivo63 labeling applications across many organismal models. However, 
researchers were poised for a revolution that never came. Although QD products have been 
introduced by a variety of vendors, there are no clinically approved QDs, and fluorescent 
dyes remain the mainstay of biological imaging. 
One obvious limitation to the clinical adoption of QDs is their toxicity.64 The most popular 
QDs for imaging applications are composed of CdSe cores with ZnS passivating shells 
(CdSe/ZnS). Cadmium is a heavy metal that yields chronic toxicity and carcinogenesis in 
humans, disrupting DNA repair, hindering mitochondrial respiration, and interfering with 
systems that employ cations of similar charge (e.g., Zn2+, Mn2+) as co-factors.16 Despite 
the fact that studies in primate models yielded no observable effects over 90 days, most of 
the administered dose remained in the organs of the reticuloendothelial system65, 
suggesting the potential for long term effects. Thus, clinicians are reluctant to employ QDs 
in humans. This problem has been addressed in recent years by the introduction of “green” 
QDs composed of alternate materials66, such as Mn-doped ZnSe50, that eliminate Cd metal 
from the nanocrystal. Some of these are even commercially available. However, despite 
these improvements, QDs remain niche products, primarily used for experiments requiring 
high numbers of multiplexed imaging targets or specific emission wavelengths. 
Other possible limitations to QD use in biological imaging are anecdotal reports of poor 
optical properties. Although QDs have shown increased resistance to photobleaching 
compared with molecular dyes60,63, several researchers have observed QD fluorescence 
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loss throughout the bioconjugation process.67,68 In particular, losses in fluorescence 
resulting from dilution, dissolution in biological buffers (particularly containing salts), and 
following purification procedures, such as centrifugal filtration or dialysis, have been 
observed. However, a comprehensive analysis has not yet been performed. Further, the 
mechanisms of QD failure are uncertain. QDs can undergo surface oxidation resulting in 
the release of free Cd2+ and generating fluorescence quenching defects at the nanocrystal 
surface.61 However, QDs exposed to high salt concentrations can also undergo aggregation 
as a result of reduced Debye charge screening of the ionic ligands on their surfaces.69 
Further, recent reports for organic phase QDs53, suggest that ligand equilibrium dynamics 
play a strong role in fluorescence loss mechanisms. 
Here, we investigated fluorescence loss resulting from QD bioconjugation processes. The 
most commonly employed QDs for biological applications are composed of CdSe/ZnS 
coated with organic compounds (e.g., polymers) to promote solubility in aqueous media.10 
Further, these QDs are often modified with antibodies or other biomolecules to permit 
targeting to specific biomarkers, typically via 1-Ethyl-3-(3-
(dimethylamino)propyl)carbodiimide (EDC)-mediated bioconjugation to –COOH groups 
on their surfaces.15 Therefore, we examined aqueous, CdSe/ZnS QDs functionalized with 
carboxylic acid terminal groups (-COOH) from 4 vendors.  
In a typical preparation for biological imaging70, QDs received from the manufacturer are 
first transferred into a conjugation buffer. Common buffers employed include borate and 
2-(N-morpholino)ethanesulfonic acid (MES) buffer. Transfer can be via simple dilution, 
especially if a small volume of QDs is diluted into a much larger buffer phase, or via 
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exchange, typically using centrifugal filtration and re-suspension. Then, conjugation 
chemicals and conjugate are added and incubated for a specified period of time. Following 
incubation, some preparations require neutralization by addition of an excess of a 
compound that reacts with the conjugation chemicals. The final product is then purified, 
usually by centrifugal filtration, dialysis, or gel filtration. 
In this work, we evaluated aggregation and fluorescence quantum yield (QY) reduction 
during the initial steps of the bioconjugation process, specifically, dilution in the original 
buffer used by the manufacturer, purification via centrifugal filtration, and dissolution in 
buffers commonly employed for bioconjugation.  
Aggregation was evaluated by measuring changes in the fluorescence of the supernatant 
following centrifugation cycles, whereas QY was evaluated using fluorometry. Thus, for 
each sample, we evaluated fluorescence loss attributed to reduced concentration, 
reductions in QY, and material loss to aggregation. The majority of studies employed red 
QDs (em = 600-630 nm) for consistency; however, some green QDs (em = 545 nm) were 
also evaluated to identify differences across emission wavelengths. In some cases, multiple 
lots were examined to evaluate lot-to-lot variation. These data provide important guidance 
on optimization strategies for QD bioconjugation and labeling protocols. 
Materials and Methods 
Materials 
To avoid potential conflicts of interest, the vendors used in this study are not disclosed. 
Red CdSe/ZnS core-shell quantum dots (QDs) (600 nm < em < 630 nm) functionalized 
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with carboxylic acid were purchased from 4 vendors. Green QDs (em = 545 nm) were 
purchased from one of these vendors. All QDs employed were shipped and stored in 
aqueous media, either pH 9, 50 mM borate buffer or pure water. Amicon ultra 0.5 mL 
centrifugal filters (cat. No. UFC505024, 100kDa) were purchased from MilliPoreSigma. 
MES Buffered Saline Packs (cat. No. 28390) and BupHTM Borate Buffer Packs (cat No. 
28384) were purchased from ThermoFisher Scientific. Rhodamine 6G (cat. No. 252433) 
was purchased from Sigma-Aldrich.  
UV-Visible Absorbance Spectroscopy 
UV-visible absorbance spectroscopy was used to estimate concentrations (against standard 
curves) of reference dye and QD solutions for quantum yield calculations. Absorbance 
spectra were obtained using a Genesys 6 UV-Vis spectrophotometer. Background 
subtraction was performed by scanning an equal volume (400 µL) of fresh solvent inside a 
Hellma absorption cuvette (path length 10 mm).  
Fluorescence Excitation and Emission Spectroscopy 
Fluorescence spectroscopy was performed to obtain the fluorescence emission and 
excitation spectra of reference dye and QD solutions. For both excitation and emission 
measurements, 80 µL of sample solution was analyzed using a sub-micro quartz cuvette. 
Fluorescence spectra were obtained with a PTI QuantaMasterTM 40 steady state 
spectrofluorometer (lamp power: 75W, detector voltage: 1100V). Emission spectra were 
collected using an excitation wavelength of 488 nm, unless otherwise specified. 
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Quantum Yield (QY) Calculations 
To evaluate fluorescence loss resulting from altered QD material properties, QY was 
calculated via comparison to a rhodamine 6G reference dye, which has an expected QY of 
95% in ethanol.71 Rhodamine 6G in ethanol was chosen because its excitation wavelength 
(488 nm) does not interfere with the range of emission wavelengths for the QDs tested (500 
nm to 700 nm). Fluorescence emission spectra for QDs were obtained by excitation at the 
first excitonic peak, 𝜆𝑒𝑥 , resulting in maximal emission or at 488 nm, as specified below. 
The latter excitation wavelength was employed to collect a full emission spectrum without 
bleed through of excitation light. From the collected spectra, QD QY was calculated using 
Equation 3.1.72 
𝑄𝑌𝑄𝐷 = 𝑄𝑌𝑟𝑒𝑓
𝐼𝑄𝐷
𝐼𝑟𝑒𝑓
 
𝜆𝑒𝑥 𝑄𝐷
𝜆𝑒𝑥 𝑟𝑒𝑓
 
𝐴𝑟𝑒𝑓
𝐴𝑄𝐷
 
𝜂𝑄𝐷
2
𝜂𝑟𝑒𝑓
2   Equation 3.1 
where 𝑄𝑌𝑄𝐷 is the measured quantum yield of the QDs, 𝑄𝑌𝑟𝑒𝑓 is the quantum yield of the 
reference dye (i.e. 0.95 for Rhodamine 6G), 𝐼𝑄𝐷 and 𝐼𝑟𝑒𝑓 are the integrated fluorescence 
intensities (for QDs and a reference, respectively) calculated by the area under the curve 
obtained using the spectrofluorometer, 𝜆𝑒𝑥 𝑄𝐷 and 𝜆𝑒𝑥 𝑟𝑒𝑓 (for QDs and a reference, 
respectively) are the excitation wavelengths used to obtain the emission spectra, 𝐴𝑄𝐷 and 
𝐴𝑟𝑒𝑓 (for QDs and a reference, respectively) are the absorbances obtained using UV-Vis 
spectrophotometry at the excitation wavelengths, and 𝜂𝑄𝐷 and 𝜂𝑟𝑒𝑓 are the refractive 
indices for the solvent containing QDs and the reference, respectively. For excitation at the 
first peak of the excitation spectra, where bleed through into the emission spectra occurs, 
𝐼𝑄𝐷 was obtained by measuring half of the emission curve from the maximum peak and 
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multiplying the measured area under the curve by 2. For QDs excited at 488 nm, 𝐼𝑄𝐷 was 
obtained by calculating the area under the full emission curve. 
Aggregation 
Fluorescence losses resulting from particle aggregation in solution were identified by 
centrifugation. When QDs aggregate, they form large clusters that precipitate easily. Thus, 
QDs in a 1.5 mL test tube were subjected to centrifugation at low speed (4000 rpm) for 1 
min. The fluorescence of the supernatant was measured to determine the amount of 
fluorescence lost to pellet formation, indicating the extent of aggregation. 
Evaluating the Effect of Dilution in Original Solvent 
QDs from 4 vendors were shipped at different concentrations in different solvents. Thus, 
to evaluate the effect of dilution, QDs were diluted across a range of concentrations using 
the original solvent, either Milli-Q water or pH 9, 50 mM borate buffer. The original 
concentrations from all vendors were too high to obtain absorbance and/or fluorescence 
spectra without saturating detectors. Thus, initially, QY was evaluated for QDs diluted in 
their original solvents to absorbance values between 0.01 and 0.1 at the longest wavelength 
absorption maxima, which was sufficient to prevent saturation of UV-Vis and fluorescence 
detectors.73 Then, further dilution using the original solvents for each sample was 
performed across a range of concentrations corresponding to an absorbance range of 0.01 
to 0.1. QY values were compared to those at the original dilution using the student t-test. 
All samples were prepared and analyzed at N  3. 
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Evaluating the Effect of Purification via Centrifugal Filtration  
To evaluate the effect of purification methods, specifically centrifugal filtration, on QD 
fluorescence loss, QD fluorescence was evaluated before and after purification via this 
method. Filtration was conducted by washing 400 µL of QD solution diluted with the 
original solvent (i.e. water, pH 9, 50 mM borate buffer) to the highest concentration tested 
in the dilution study using Amicon ultra 0.5 mL centrifugal filter devices at 12,000 rcf for 
3 minutes. Then, concentrated QDs were immediately resuspended to the original volume 
of 400 µL in the original solvent. Filtration was repeated up to 3 times, and QY was 
measured after each repeat. QY values were then compared to those before filtration using 
the student t-test. All samples were prepared and analyzed at N  3. 
Effect of Buffer Exchange 
Centrifugal filtration was also used for buffer exchange studies. QDs were processed as 
above, except, after removing the original solvent, QDs were washed with MilliQ water 
before dispersion into a new buffer. For QDs shipped in water, QDs were resuspended in 
new buffer after only one washing cycle. For QDs shipped in other solvents, three washing 
cycles were performed prior to dispersion into the new buffer. Buffers tested included pH 
4.7, 0.1 M MES buffer and pH 9, 50 mM borate buffer because they are commonly used 
in bioconjugation procedures. In addition, pH 7.3, 50 mM borate buffer was tested to 
examine the effect of buffer ionic strength on QD stability. QY values were then compared 
to those before buffer exchange using the Student’s t-test. All samples were prepared and 
analyzed at N  3. 
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Results and Discussion 
Initial QY Calculations 
QDs received from vendors were highly concentrated. Thus, samples were diluted to avoid 
saturation of detectors for initial measurements. QY was then determined at this initial 
concentration using excitation wavelengths corresponding to the first excitation peak and 
also at 488 nm (to prevent excitation bleed through in the emission spectrum) (Figure 25 
(a) summary and (b) full spectra).  
Measured QYs ranged from ~ 60% or 40% for green and red QDs, respectively, to as little 
as ~ 5% (red QDs). All vendors provided expected QY values for their QDs, although the 
methods of measurement were not indicated. QY values measured by our methods, 
following dilution and compared to a known reference, were substantially lower than 
reported values in all but 2 cases (Red, vendors #2 and 3). This may result from the 
methodology employed (i.e., QY measurement against a reference vs. use of the integrating 
spheres74), which prevented evaluation at the as shipped concentration. QYs of > 50% are 
generally desired for imaging applications.75 Nonetheless, QDs with QY < 10% have been 
successfully employed for cell labeling76, suggesting that even products with low QY may 
still result in successful imaging results. We also observed only slight differences in QY 
values regardless of the excitation energy employed (i.e., first excitation peak vs. 488 nm), 
with the largest difference observed for Vendor #1 Red. Thus, we do not believe that 
excitation wavelength contributes to this discrepancy between measured and reported 
values. In subsequent experiments, an excitation wavelength of 488 nm was employed to 
permit the full emission spectra to be collected without excitation bleed through.  
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Effect of Dilution with Original Solvent 
Most bioconjugation and labeling protocols require dilution of QD stock solutions before 
use. QD stability is critically linked to the local environment, and in particular, the ionic 
strength of the media.77 The presence of proteins and other additives in cell culture medium 
and serum can further alter this response.78 Thus, we evaluated the influence of dilution on 
QD fluorescence losses resulting from aggregation and reduced QY. To decouple 
fluorescence QY losses resulting solely from dilution from those resulting from buffer 
incompatibility, we first evaluated QD fluorescence loss upon dilution with the original 
aqueous solvent in which QDs were shipped and stored. QDs were diluted across a range 
of concentrations consistent with absorbance values between 0.01 and 0.1 at the longest 
wavelength absorption maxima, with maximal concentration values corresponding to those 
used in Figure 25 (Figure 7, Figure 26).  
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Figure 7 Photoluminescence intensity (PL) and QY of red QDs from four vendors as a 
function of concentration. Fluorescence intensity is concentration dependent and thus is 
expected to decline with dilution, whereas QY is not.  
 
Fluorescence intensity, which is correlated to the total number of photons emitted, is 
concentration dependent, and thus should decline with dilution. However, QY, which 
reflects the number of photons emitted over those absorbed, is concentration independent, 
provided that QDs are not affected by the local aqueous environment. As expected, 
fluorescence intensity for all vendors declined with dilution (Figure 7). Also, for QY, no 
statistical difference (α = 0.05) was observed across the samples and dilutions investigated; 
suggesting that the borate buffer and water in which products were shipped did not 
influence QD surfaces and their photoluminescence emission sites. Further, no aggregation 
was observed, suggesting colloidal stability in these original aqueous solutions. 
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To enhance rigor of our analysis, we repeated these experiments with a second lot of 
material. Unfortunately, only one vendor (Vendor #1) had multiple lots available for 
purchase, thus our analysis was limited to products from Vendor #1 (Figure 26). The 
expected QY reported by the manufacturer for Lot 2 was higher than that of Lot 1 by 6%. 
However, the measured QYs for these two lots were not statistically different (α = 0.05) 
across the range of concentrations investigated. Thus, the second lot displayed a slightly 
greater difference from the manufacturer’s reported QY. No aggregation was observed in 
these studies. Therefore, in this limited evaluation, we did not observe substantial lot-to-
lot variability, although further investigation of many lots from each of the vendors would 
be required to conclusively evaluate this variable.  
Next, we evaluated the influence of emission wavelength on fluorescence loss. CdSe/ZnS 
QD fluorescence derives in part from the nanocrystal surface3, which is much less stable 
than the interior of the nanocrystal. Thus, smaller QDs (emitting toward the blue end of the 
spectrum), which have higher surface to volume ratios, are expected to exhibit a greater 
propensity for QY loss as a result of surface defects than larger QDs (toward the red end 
of the spectrum). Therefore, we evaluated fluorescence loss upon dilution for green-
emitting carboxylate-functionalized CdSe/ZnS QDs (em =545 nm) from Vendor #1. For 
these materials, the manufacturer’s reported QY was lower than that of red QDs (Lot 1) by 
25%, but the measured QY was higher than that of red QDs (Figure 26 (B) vs. Figure 25 
(a)). Consistent with our previous results, QY measured after dilution was lower than the 
manufacturer’s reported value. Although the difference between the manufacturer’s 
reported QY and the measured QY after dilution was lower than that observed for red QDs, 
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green QDs showed a larger standard deviation in QY values. This could potentially result 
from the larger surface to volume ratio of green QDs, reducing stability. However, no 
aggregation was observed across these experimental conditions, suggesting colloidal 
stability was maintained. 
Effect of Centrifugal Filtration 
Most bioconjugation protocols require concentration and purification steps70, and for QDs, 
centrifugal filtration devices are often used for these purposes. Purification can result in 
reduced fluorescence intensity, in part from loss of sample in the filter, but also from 
increased solution ionic strength, which lowers colloidal stability.77 Thus, we investigated 
fluorescence losses resulting from centrifugal filtration and up to 3 washing steps. For these 
experiments, samples were investigated at the highest concentration tested in the dilution 
study and were washed with the aqueous media in which they were shipped and stored. 
Because of possible material losses during filtration (i.e., entrapment in the filter), 
absorbance for QY calculations was determined at the beginning of each filtration cycle. 
Thus, the reported values are concentration-corrected. 
All samples experienced reductions in total fluorescence intensity (Figure 8, Figure 27), in 
some cases by as much as 96% (Vendor 4), which could result from either loss in the filter 
or reduction in QY. Specific investigation of QY indicated modest declines (Table 1), 
suggesting that much of the reduction in fluorescence intensity reflects material loss on the 
filter. Sample QY was generally stable against a single filtration cycle; however, samples 
from Vendors 2-4 displayed statistically significant reductions in QY with increasing 
numbers of washes. QDs from Vendor 1 displayed mixed results, although they were more 
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resistant to QY reduction than all competing vendors. QDs from Red Lot #1 demonstrated 
a statistically significant reduction in QY after 3 washes, whereas as Red Lot #2 and the 
Green Lot did not demonstrate reduced QY across the three washes performed. For green 
QDs; however, sample-to-sample variation, reflected by their relatively larger standard 
deviations, was consistently observed (Table 1). This is consistent with the larger variations 
observed in our dilution study as well. However, conclusive results would require a larger 
study with multiple lots from each vendor. As in our previous studies, aggregation was not 
observed across all experiment conditions, suggesting colloidal stability in original 
aqueous media was not affected by centrifugation or filtration steps. 
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Figure 8 Photoluminescence (PL) intensity and QY of red QDs from four vendors (fixed 
concentration) after centrifugal filtration repeated up to 3 times. 
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Table 1 QY of QDs Following Centrifugal Filtration and QDs in Different Buffers 
Filtration 
Vendor 1 
Red, Lot 1 
(0.1 µM) 
Vendor 1 
Red, Lot 2 
(0.1 µM) 
Vendor 1 
Green 
(0.25 µM) 
Vendor 2 
Red 
(0.1 µM) 
Vendor 3 
Red 
(0.06 µM) 
Vendor 4 
Red 
(0.5 µM) 
Pre-Wash° 39.2 ± 0.9 40.0 ± 2.7 54.8 ± 4.7 19.82 ± 2.1 22.5 ± 0.5 5.9 ± 0.1 
Wash 1 36.3 ± 0.9 41.4 ± 1.4 57.3 ± 2.8 19.06 ± 0.6 21.4 ± 0.3 3.5 ± 0.3* 
Wash 2 37.1 ± 0.4 41.9 ± 1.2 57.4 ± 5.0 17.4 ± 0.3* 18.9 ± 0.4* 1.8 ± 0.2* 
Wash 3 33.9 ± 0.8* 40.9 ± 0.9 55.8 ± 3.3 16.6 ± 0.6* 18.3 ± 0.3* 2.3 ± 1.5* 
Buffer 
Vendor 1 
Red Lot 1 
(0.1 µM) 
Vendor 1 
Red Lot 2 
(0.1 µM) 
Vendor 1 
Green 
(0.25 µM) 
Vendor 2 
Red 
(0.1 µM) 
Vendor 3 
Red 
(0.06 µM) 
Vendor 4 
Red 
(0.5 µM) 
Borate 
pH 9, 50 mM 
33.9 ± 0.8 41.0 ± 0.9 55.8 ± 3.3° 
24.12 ± 
0.8* 
17.2 ± 0.7* 3.1 ± 0.1* 
Water 36.4 ± 0.5* 33.7 ± 0.6* 52.1 ± 2.0* 19.8 ± 0.2 22.5 ± 0.5 3.5 ± 0.3 
MES 
pH 4.7, 0.1 
M 
Aggregation Aggregation Aggregation 13.6 ± 0.7*  
17.3 ± 
0.05*  
1.1 ± 0.2*  
°As reported in Figures 1,S2; *indicates statistical difference (α = 0.05) from pre-wash 
values 
*indicates statistical difference (α = 0.05) between QY before and after buffer exchange 
 
Because QY values are concentration corrected, these losses cannot be attributed to product 
loss during washing. Thus, the most likely cause for reduced QY during centrifugal 
filtration is loss of surface ligand, which is a well-documented problem during solution 
exchanges.68 However, QY reductions were not observed with sample dilution, which 
would have been expected if ligand loss were driven by equilibrium reactions alone. We 
hypothesize that ligand loss could occur during centrifugal filtration, but not dilution, 
because of the additional shear forces applied during this process. This hypothesis could 
be further confirmed by quantitative NMR experiments to examine ligands on the QD 
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surface.79 An alternative possible cause of reduced QY is surface oxidation80, which could 
be evaluated using x-ray photoelectron spectroscopy or cathodoluminescence81. It is 
notable; however, that the surface changes that resulted in reduced QY did not result in 
reduced colloidal stability as no aggregation was observed throughout the study. These 
data suggest that filtration steps should be limited in number to reduce QY losses 
throughout the purification process. 
Effect of Buffer Exchange 
Bioconjugation protocols are typically performed in buffers such as MES70, although some 
QD vendors recommend borate buffer. Biological buffers inherently present solutions with 
different pH and ionic strength than water, and as such could affect colloidal stability.77 
Thus, we examined the effect of QD dissolution in: water; pH 9, 50 mM borate buffer (i.e., 
recommended by one vendor for bioconjugation); and pH 4.7, 0.1 M MES buffer 
(consistent with common bioconjugation protocols70) to examine the effect of dispersing 
QDs in solvents with different pH and ionic strengths. Buffer exchange was performed 
using centrifugal filtration to reduce the volume of the original solvent, followed by 
dispersion in the new solvent. Three washes in the new solvent were performed before 
measurement to ensure removal of residual solvent. QD concentrations employed were 
consistent with those used in the centrifugal filtration study. 
Products generally displayed highest QYs in the buffers in which they were supplied (i.e., 
either water or borate buffer) (Figure 9 and Table 1). Thus, there were no trends across all 
4 vendors indicating an ideal buffer that maximized QY for all products. However, 
dissolution in MES buffer, recommended in many bioconjugation protocols, yielded 
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decreased stability or statistically significant declines in QY for all products tested. QDs 
from Vendor 1, regardless of lot number or color, aggregated instantaneously in MES 
buffer (Figure 28). QDs from vendors 2 and 4 did not demonstrate visible aggregation, but 
fluorescence emission peaks were red-shifted, suggesting aggregation. QYs for QDs from 
these two vendors were also reduced, although by levels roughly consistent with those 
observed in response to centrifugal filtration (3 washes), suggesting that these QY losses 
most likely result from centrifugal filtration processes and not buffer incompatibility. QDs 
from Vendor 3 did not present observable aggregation or red-shifted emission peaks; 
however, there was a slight, statistically significant decline in QY compared to that in other 
buffers. This decline was consistent with that observed during centrifugal filtration studies, 
and most likely can be attributed to purification rather than buffer incompatibility. To 
evaluate the effect of pH, in a more limited set of samples, we examined QD compatibility 
with pH 7.4, 50 mM borate buffer, which was recommended by one of the vendors as a 
conjugation buffer (Figure 29). QD samples from Vendor 1 (Lot 2) and Vendor 2 were 
stable in pH 7.4 borate buffer, consistent with prior results using pH 9, 50 mM borate, and 
did not demonstrate statistically significant differences in QY from measurements 
conducted in their original buffers.  
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Figure 9 QY of (a) red QDs from four vendors in different buffers and (b) from vendor 1: 
red QDs, lots 1 and 2 and green QDs. Star indicates that significant aggregation was 
observed, precluding measurement of QY. 
 
Colloidal stability is typically inversely proportional to ionic strength, with increasing ionic 
strength yielding greater Debye screening and therefore reduced colloidal particle 
stability.77 However, the buffers used in this study had ionic strengths of 4.7 mM and 104.1 
mM for MES and pH 9 borate buffers, respectively. Thus, QDs in borate buffer would be 
expected to demonstrate the least colloidal stability, which is contradictory to our findings. 
These results indicate that buffer incompatibility, separate from that attributed to ionic 
strength, can induce aggregation of commercial QD products (Vendors 1, 2, and 4 in MES 
buffer), and should be carefully considered when designing QD conjugation protocols. 
Conclusion  
This study evaluated the colloidal stability and QY of –COOH terminated CdSe/ZnS QDs 
from 4 commercial vendors. These materials were chosen because they are the most 
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common QDs employed in biological imaging studies. Three processes required in 
bioconjugation protocols were examined: dilution in the manufacturer’s original buffer, 
purification via centrifugal filtration, and dilution in biological buffers employed in 
bioconjugation protocols. Across the range of concentrations investigated, all products 
investigated demonstrated unchanged QY and no aggregation upon dilution in the solvent 
in which they were shipped. Further, although limited investigation was performed, no lot 
to lot variation was observed. However, the measured QYs for nearly all vendors were 
lower than those reported by the manufacturers. This may result from the method of 
measurement. The most significant declines in QY were observed in response to centrifugal 
filtration, with declines increasing as a function of increasing number of wash cycles. The 
most significant declines in colloidal stability were observed in MES buffer. These data 
suggest caution in developing bioconjugation protocols, which should employ the 
minimum number of purification and washing cycles. Further, in this limited study, ionic 
strength was not a predictor of QD stability in a given buffer. Thus, care should be taken 
to evaluate stability experimentally when developing a new protocol. These results provide 
some of the first systematic investigation of stability and QY for commercial QD products 
during preparation steps for biological use. 
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Chapter 4. Biomolecular detection, tracking, and manipulation using a magnetic 
nanoparticle-quantum dot platform 
This chapter describes a magneto-fluorescent detection and separation platform based on 
quantum dots and superparamagnetic iron oxide nanoparticles applied to protein and DNA. 
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Introduction 
Fluorescence and magnetism have long been used for real-time detection and quantification 
of molecules. Efforts to improve these technologies have typically focused on increasing 
sensitivity, specificity, and multiplexing capability. Quantum dots (QDs), with their broad 
absorption cross-section, narrow emission spectra, and photostability, have attracted 
significant attention for fluorescent labelling applications.83 For sensing, QDs have been 
applied using techniques such as Förster resonance energy transfer (FRET),84 fluorescence 
ratiometry, electrochemiluminescence, and photo-electrochemistry.85 Concurrently, 
superparamagnetic iron oxide nanoparticles (SPIONs) have been applied in imaging, 
manipulation, and biosensing.86 For sensing, SPIONs are most commonly used to 1) move 
and/or concentrate a targeted entity or 2) to detect analytes based on their paramagnetic 
properties.  For both applications, SPION properties are critical features, combined with 
the magnitude of the magnetic energy gradient and/or detection instrument.87 For example, 
analytes can be detected directly via superconducting quantum interference devices 
(SQUID) analysis of SPION-labelled entities.88 However, these platforms typically lack 
multiplexing capability, and are hence unable to perform simultaneous sensing and 
manipulation operations. Further, the current practical size for individual SPIONs used in 
these applications is ~ 20 nm.89 However, many individual, small SPIONs can also be 
combined into a larger aggregate to achieve an effective increase in magnetic volume.90 
Recently, several groups have developed multimodal detection probes that combine QDs 
and SPIONs for simultaneous molecular sensing and manipulation.91 Detection 
mechanisms can include QD fluorescence quenching by electron and energy transfer 
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mechanisms or direct fluorescent labelling, whereas magnetic capability is employed for 
analyte separation. However, many of these schemes employ heterofunctional composite 
nanoparticles (NPs), such as core-shell structures,92,93 which can yield false positive 
binding events. Such platforms may lack sensitivity and specificity.  
Based on our development of polymer micelle-NP encapsulant composite materials, we 
developed a versatile technology that utilizes SPION and QD micelles and engineered 
magnetic fields to simultaneously manipulate and track different biomolecules in parallel. 
This approach groups together several individual QD or SPION encapsulants, increasing 
QD fluorescence signal94 and the cumulative magnetic volume90. In this approach, 
individual micelles containing multiple QDs or SPIONs are conjugated to molecules that 
detect the analyte, but do not target each other. These micelle “bricks” are thus assembled 
into hierarchical structures by binding target analyte “mortars” (Figure 10), whose size is 
limited by the available analyte concentration. This approach permits detection via 
fluorescent signals, measurement of hierarchical structure size, and magnetic 
quantification, a tri-fold duplication of signals that could be used for internal quality 
control. Further, unlike approaches that rely on detection alone, this approach permits 
isolation and quantification of target biomolecules. False positives are reduced by the 
requirement of both fluorescent and magnetic micelle binding events to register a detection 
event. 
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Figure 10 Micelle-Based Aggregation Assay. A detection event occurs when a fluorescent 
micelle and magnetic micelle both bind to (A) DNA or (B) protein analytes, forming a (C, 
D) hierarchical material. As analyte concentration increases, additional micelles join the 
aggregate. Green and red QD micelles were used for ssDNA and protein analytes, 
respectively. 
 
Here, we implemented this scheme to detect model streptavidin protein and p53 DNA 
analyte molecules via assembly of QD-SPION composite materials. The resulting 
fluorescent and magnetic structures were transported, manipulated, and separated via user- 
controlled magnetic fields that acted on SPION constituents, whereas fluorescent QD 
components permitted analysis and quality control through real-time optical 
characterization. To determine sensitivity, we compared analyte concentration against a 
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fluorescence standard curve, whereas to measure specificity we examined detection of 
complimentary DNA vs. DNA with 1 or 2 base pair mismatches. Parallel and sequential 
separation of different biomolecules was also demonstrated by concurrent or sequential 
addition of functionalized SPION micelles. Thus, this approach complements existing 
detection platforms by enabling simultaneous separation and detection, which can be 
multiplexed to simultaneously detect both proteins and DNA, and provides multiple 
potential measurement modalities for internal quality control. 
 
Materials and Methods 
Materials 
Quantum dots supplied in decane (λem = 545 nm (green), Cat No. Q21791MP and λem = 
605 nm (red), Cat No. Q21701MP), N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC) (Cat No. 22980),  sulfo-N-hydroxysuccinimide (sulfo-NHS) (Cat No. 
24510), and pentyl-amine biotin (Cat No. 21345) were purchased from ThermoFisher 
Scientific (Waltham, MA). 5nm SPIONs (Cat No. SOR-05-50) were purchased from 
Ocean NanoTech (San Diego, CA). Carboxyl-terminated poly(styrene-b-ethylene oxide) 
PS(9500)-b-PEO(18000) (Cat No. P5755-SEOCOOH) was purchased from Polymer 
Source, Inc. (Dorval, QC, Canada). Poly(vinyl alcohol) (PVA, 13,000-23,000 Dalton, 87-
89% hydrolyzed, Cat No. 363170), MES buffer (2-(N-morpholino)ethanesulfonic acid (Cat 
No. M8902), and ssDNA were purchased from Sigma Aldrich (St. Louis, MO). Thiol 
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functionalized methoxy polyethylene glycol (Cat No. MPEG-SH-5000) was purchased 
from Laysan Bio, Inc (Arab, AL). 
Micelle Synthesis 
As described previously94,95, the interfacial instability approach was used to synthesize 
micelles containing either QDs or SPIONs. For QDs, stock solutions as supplied by the 
manufacturer in decane were first transferred to chloroform. QDs (100 µl) were 
precipitated by adding 450 µl of a 1:2 isopropanol: methanol solution. The pellet was then 
re-suspended in chloroform to a concentration of 0.1 µM. SPIONs were directly dissolved 
in chloroform at 3.45 µM. Carboxyl-terminated poly(styrene-b-ethylene oxide) PS(9500)-
b-PEO(18000) at 36.4 µM in chloroform was used to encapsulate NPs. The aqueous phase 
consisted of poly(vinyl alcohol) (PVA) dissolved in water at 5 mg/ml. Micelles were 
generated by mixing 10 µl polymer solution and 200 µl of QD or SPION solution with 800 
µl of the aqueous PVA phase via sonication. Mixtures were left to evaporate for 1-2 hours; 
formation of a clear, transparent solution indicated successful encapsulation and micelle 
formation. Micelles can be stable for weeks to months, depending on synthesis 
conditions.96 
Micelle Bioconjugation 
As model systems, biotin was used to capture avidin proteins and p53 DNA was used as a 
DNA analyte. For avidin protein detection, both QD (red) and SPION micelles were 
functionalized with biotin. For p53 DNA detection, QD (green) and SPION micelles were 
functionalized with distinct ssDNA sequences (Table 2) that do not bind each other, but 
hybridize with the same target DNA sequence derived from the mRNA of the tumor 
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suppressor protein p53 (NCBI ref. seq. NM_000546.4). In addition, capture experiments 
were conducted with single and double mutation sequences to assess specificity. Mutation 
locations were chosen randomly, but were excluded from ssDNA locations near NP 
attachment points. 
 
Micelles were modified with either protein or ssDNA using N-(3-Dimethylaminopropyl)-
N’-ethylcarbodiimide hydrochloride (EDC) chemistry.15 First, carboxylated micelles 
synthesized in water were re-suspended in pH 5.7 MES buffer. Then, this solution was 
mixed with EDC, sulfo-NHS, and pentyl-amine biotin or ssDNA at a molar ratio of 
1:1000:2500:100 corresponding to micelles: EDC:sulfo-NHS:Biotin or ssDNA. After 
overnight incubation at room temperature, conjugated micelles were purified by dialysis 
against distilled, deionized water. 
Transmission Electron Microscopy (TEM) 
Samples were prepared by placing 10 µL of sample onto a silicone pad. Transfer to 
formvar/carbon-coated nickel grids was achieved by exposing the grids to the sample 
droplet for 2 minutes. Samples were negatively stained using phosphotungstic acid (PTA, 
1%) by placing the grid on a 10 µl droplet for 2 minutes. Excess PTA was removed with 
Table 2 NP and Analyte DNA Sequences 
ssDNA  Sequencea 
QD NH2C6-TGAAACGCAAGCCCGA 
SPION                                                          CCCTGACCTAACCGCC-C7NH2 
Target               ACTTTGCGTTCGGGCTGGGACTGGATTGGCGG 
1 bp mut.               ACTTTGTGTTCGGGCTGGGACTGGATTGGCGG 
2 bp mut.               ACTTTGTGTTCGGGCTGGGACTGGATTGGAGG 
aMut. = Mutations, indicated with bold characters. Same colours indicate complimentary sequences. 
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filter paper. Micelles and micellar aggregates were then imaged using a FEI Tecnai G2 Bio 
Twin TEM. 
Dynamic Light Scattering (DLS) 
Hydrodynamic particle size was characterized using dynamic light scattering (Brookhaven 
Instruments Corporation, BI 200SM). Sample concentration was adjusted by addition of 
water to obtain a scattered light intensity between 10 and 200 kCPS (kilo-counts per 
second) at a laser wavelength of 633 nm and a detection angle of 90°. Number weighted 
size was measured for each sample. The size of the micelle composites for each analyte 
concentration was measured in triplicate, and each replicate was measured three times; the 
average value was recorded. 
Fluorescence Imaging 
Samples were imaged using a 100x oil immersion objective on an Olympus IX71 
fluorescent microscope. A 100 W mercury lamp was used to generate excitation at λex = 
488 nm, and a long-pass emission filter was employed to collect emission signal. Images 
were collected with an Olympus DP70 CCD camera or an EMCCD camera (Photometrics, 
AZ) with Metamorph software. All image processing and analysis were performed using 
NIH ImageJ software. 
Fluorescence Intensity Quantification and Measurement of Limit of Detection 
QD and SPION micelles were used as prepared, at an estimated concentration of 7 x 10-10 
M. For each experiment, micelles were incubated with analyte (10-10 - 10-18 M) for ~ 20 
min. Then, micelle aggregates were viewed on an Olympus IX71 fluorescence microscope 
equipped with an Evolve Photometrics EMCCD camera. A stream acquisition of 50 images 
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was recorded for each location, and at least 3 locations were analyzed for each 
concentration. Each fluorescent spot was circled in ImageJ and the total fluorescence 
intensity was determined. The highest value of total fluorescence intensity among 50 
frames was recorded to eliminate interference from QD blinking among constituent 
particles. This value was compared to that obtained for a single micelle using the same 
procedure to determine the number of QD micelles bound. The first fluorescence 
concentration that could be distinguished from that of the control with no analyte was 
reported as the limit of detection. 
Particle Tracking 
Hierarchical aggregate trajectories were analyzed using MTrackJ plugin97 available in 
ImageJ. Particle sizes were obtained from the mean square displacement (MSD) using the 
Stokes-Einstein equation as described previously.98 Briefly, the 2D mean squared 
displacement was calculated by tracking the location of fluorescent aggregates. The 
diffusion coefficient was then calculated as follows: 
𝑴𝑺𝑫 = 𝟒𝑫𝒕   Equation 4.1 
where 𝑫 is the diffusion coefficient, and 𝒕 is time.99 Then, the Stokes-Einstein equation 
was applied to determine particle size: 
𝑫 =
𝒌𝒃𝑻
𝟑𝝅𝝁𝒅𝒑
  Equation 4.2 
where 𝑫 is the diffusion coefficient, 𝒌𝒃 is Boltzmann’s constant, 𝑻 is the temperature, 𝝁 is 
the viscosity, and 𝒅𝒑 is the particle diameter. 
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Fabrication of Magnetic Traps 
Nano-composites were trapped and manipulated using a nano-scale magnetic platform 
consisting of patterned wires or disks in the presence of programmable magnetic fields 
(Figure 30). The wires and disks were patterned on silicon wafers using electron beam 
lithography. Two layers of e-beam resist (methylmethacrylate and polymethyl 
methacrylate) were spin-coated onto the silicon wafer, baked, and exposed to electron 
beams which draw the desired patterns. Following development, a 40 nm-thick layer of 
magnetic material was deposited using magnetron sputtering. (The magnetic material used 
was chosen based on magnetic coercivity. For wires, Co0.5Fe0.5 was chosen so that magnetic 
domains would remain mostly unchanged during experiments, whereas for disks, Ni0.8Fe0.2 
was chosen so that disk magnetic domains could be easily rotated.) The e-beam resist and 
excess magnetic material were lifted off with acetone. The wires (but not disks) were 
initially magnetized in a desired orientation by applying a temporary ~1 kOe external 
magnetic field. To minimize surface adhesion and non-specific binding, a 1 nm seed layer 
of Ni0.8Fe0.2 and a 5 nm layer of Au was sputtered atop the entire surface, followed by self-
assembly of a thiol-bound PEG monolayer. 
Magnetic Manipulation of Particles and Assemblies  
The trapping platform consisted of a patterned silicon wafer as well as four electromagnets 
and one wire coil (Figure 31). Programmable electrical currents passing through the 
electromagnets and coil were used to control magnetic fields in three dimensions. The four 
electromagnets applied field components in the plane of the wafer, whereas the wire coil 
surrounded the wafer and applied an out-of-plane field component. The out-of-plane field 
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served to strengthen or weaken traps that existed at wire vertices or at the peripheries of 
disks, whereas the in-plane fields guided the movement of particles manipulated across the 
silicon wafer.100 The wafer was placed beneath a 100x oil immersion objective lens in an 
Olympus microscope, where fluorescence imaging was performed. Images and videos 
were recorded using an Olympus DP70 CCD camera.  
For each experiment, QD and SPION micelles were used as prepared, at an estimated 
concentration of 7 x 10-10 M. Analyte concentration (i.e., 10-10 M) was chosen such that the 
magnetic strength of the micelle aggregates was sufficient to easily manipulate them. 
Micelles and analytes were incubated together for ~ 20 min. prior to magnetic capture. 
Three different experiments were performed. In the first experiment, magnetic 
manipulation of magnetic-fluorescent aggregates formed in the presence of ssDNA 
analytes was demonstrated on both disk and nanowire platforms to provide proof of 
concept. In the second experiment, avidin and ssDNA analytes were added together with 
their respective complementary particles and simultaneous magnetic manipulation of DNA 
and protein on a nanowire platform was shown. In the third experiment, avidin and ssDNA 
analytes were added sequentially and sequential manipulation of protein and DNA analytes 
was shown on a nanowire platform. 
Results and Discussion 
Hierarchical Assembly of Micelle “Bricks” with Analyte “Mortar” 
Multiple QD or SPION NPs were incorporated into individual micelles through the self-
assembly of amphiphilic polymers in an aqueous environment.94,95 QD micelle sizes were 
extensively analyzed previously.94 SPION micelles were spherical and ~40 nm in diameter 
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(i.e., 42 ± 13 nm) as confirmed by DLS and transmission electron microscopy TEM (Figure 
11), consistent with sizes of QD micelles. This approach overcomes some limitations of 
using individual SPIONs by aggregating multiple SPIONs together to increase overall 
magnetic volume and therefore magnetic susceptibility. 
Figure 11 Dynamic light scattering (DLS) and transmission electron microscopy (TEM) 
analysis of SPION micelle size indicated an average size of 42 ± 13 nm, similar to that of 
QD micelles. 
 
Individual micelle “nano-bricks” were assembled into hierarchical structures using analyte 
“nano-mortars” comprised of avidin proteins or ssDNA derived from the p53 mRNA 
sequence. These hierarchical structures, containing both fluorescent QD and magnetic 
SPION micelles (e.g., Figure 10 schematic) were ~50-200 nm in diameter. Using ssDNA 
analytes for proof of concept, aggregate size and fluorescence intensity were demonstrated 
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to be dependent on the concentration of the analyte mortar (Figure 12). QD fluorescence 
intensity was correlated with aggregate size as measured via aggregate particle tracking, 
and few aggregates > 100 nm were observed (Figure 32). At micelle concentrations of ~ 
10-10 M, nanoassemblies could be formed in solutions as dilute as 10-16 M (i.e., 0.1 fM) 
(i.e., fluorescence limit of detection), which is improved compared to similar magnetic 
aggregation assays (e.g., 100 pM101). These results are also consistent with state-of-the art 
QD assays that, unlike our aggregation-based system, are based on Förster Resonance 
Energy Transfer (FRET) (e.g., ~ fM102). 
 
 
Figure 12 Nanoassembly size increases with increasing target biomolecule concentration 
(i.e., “nanomortar”, here, p53 single stranded DNA). Insets: Representative TEM images 
of nanoassemblies at the corresponding concentrations of p53 single stranded DNA. 
(Micelle concentration ~ 7 x 10-10 M) 
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Magnetic Collection of Assemblies and Analyte Detection 
The proposed approach permits not only detection, but also magnetic isolation of analytes 
through the use of user-controlled magnetic fields. Engineered magnetic gradients95,100 
exerted forces on nanoassembly constituent SPIONs to generate motion in a desired 
direction. Controlled motions across a surface were the result of adding a tunable, weak 
electromagnetic field to the strong, arrayed magnetic field gradients of a micro-patterned 
magnet chip.95,100 As an example, assembly circular motion was induced using 
micropatterned magnetic disk arrays (Figure 13A, Appendix E Supplementary Video 1), 
and translational motion was induced via vertex-to-vertex hopping along micropatterned 
magnetic zigzag wires (Figure 13B, Appendix E Supplementary Video 2). Typically, ~85% 
of the fluorescent spots trapped at magnetic vertices (e.g., hybridized nanoassemblies) 
responded to the modulation of the tunable weak electromagnetic field by moving with 
similar velocity vectors. Nanoassemblies that did not move in a synchronized fashion were 
most likely agitated by occasional liquid flow. Although not investigated here, this suggests 
that liquid flow could also be exploited to provide additional transport modalities through 
microfluidics, potentially permitting platform integration with existing lab-on-a-chip 
devices.  
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Figure 13 Trapping, transport, and manipulation of composite nanoassemblies (A) on 
micro-disks, (B) micro-wires, and (C-E) with multiplexing (i.e., still frame images from 
Appendix E Supplementary Videos 1-5). In (A) and (B), fluorescent-magnetic 
nanoassemblies (molecular target: p53 ssDNA, 10-10 M) moved around micro-disks and 
between zigzag micro-wires, respectively, via investigator-controlled modulation of the 
magnetic field. (C) Red avidin protein (10-10 M) and green p53 DNA (10-10 M) 
nanoassemblies were simultaneously transported via investigator-controlled vertex-to-
vertex hopping. (D, E) Sequential separation of protein and DNA-based nanoassemblies. 
(D) Red, magnetic avidin protein nanoassemblies were transported via investigator-
controlled vertex-to-vertex hopping, whereas green, non-magnetic p53 DNA 
nanoassemblies (lacking the magnetic SPION component) moved only as a result of 
Brownian motion or liquid flow. (E) Green, magnetic p53 DNA nanoassemblies were then 
formed on the same sample by the addition of complimentary DNA-SPIONs, which were 
transported via investigator-controlled vertex-to-vertex hopping. The arrows in (A-E) 
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indicate movement of nanoassemblies from the previous frame and are color-coded to 
represent distinct assemblies. 
 
Key to this approach is the ability to tune the electromagnetic field via user input, with 
simultaneous optical readout (via QD fluorescence) of the assembly response. In contrast 
to manipulation approaches based on scanning probe microscopy103 and synthetic 
chemistry104, the strong and stable fluorescence of QDs105 enables direct visualization and 
detection of nanoassembly motion in situ with a fluorescence microscope. The ability to 
visualize transport and assembly directly also provides a method of quality control in 
detection. For example, positive detection events required both QD fluorescence and 
magnetic mobility to indicate nanoassembly formation and thus analyte detection.  
These properties were used to assess the sensitivity and specificity of the process. 
Assemblies that underwent motion in a magnetic field could be characterized via their 
fluorescence intensity. As a first experiment, ssDNA analyte assemblies were tracked via 
their fluorescence (Figure 10A). As analyte concentration was increased, assembly size 
and fluorescence intensity increased (Figure 10C, Figure 10D, Figure 12). Reliable 
assembly of clusters ranged from 2 to 27 micelles in solutions containing ~300-1000 
biomolecules in the 5 µl samples used in this study. Biomolecular detection was achieved 
without any amplification steps (e.g., polymerase chain reaction), and benefitted from the 
significant signal amplification arising from multiple QDs encapsulated in each QD 
micelle. Although future work should investigate random sequences and sensitivity of 
avidin detection in complex solutions containing additional proteins, no detection event 
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(i.e., magnetic motion and corresponding fluorescent signal) was recorded for a 32-
nucleotide sequence (i.e., p53 ssDNA) with double or single base pair mismatches (Table 
2). The high sensitivity and specificity achieved with this small sample volume may be 
attributed to combining the strong local magnetic field gradients of micro-patterned arrays, 
which permit isolation of small numbers of biomolecules, and the high fluorescence 
intensity of constituent QDs, which provide quantitative read-out, into an integrated 
system.  
Multiplexed Collection of Protein and DNA Analytes  
This approach also permits simultaneous isolation of both protein and DNA on the same 
platform. Because constituent QDs exhibit size-dependent fluorescence, a large absorption 
cross-section, and broad excitation spectra105, nanoassemblies may be color-coded and 
their motion simultaneously observed with a single filter set.95 Color-coded QD-SPION 
nanoassemblies containing either avidin (red, λemission = 605 nm) or p53 ssDNA (green, 
λemission = 545 nm) mortars were generated. Red protein and green DNA nanoassemblies 
were co-transported via investigator-controlled, vertex-to-vertex motions, confirming the 
ability of this technology to manipulate two types of molecular targets simultaneously 
(Figure 13C, Figure 14A, Appendix E Supplementary Video 3). These experiments 
demonstrate that the intrinsic photoluminescent properties of the QD element may be used 
to visualize multiplexed control of materials transport. In contrast, observation of rapid, 
dynamic events using molecular dyes would be infeasible because of the time required to 
collect and superimpose multiple images from separate color channels. 
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Figure 14 Mean squared displacement (MSD) vs. time for protein (red, upper panel) and 
DNA (green, lower panel) nanoassemblies. Representative arrows in panels indicate points 
at which MSD vs. time deviates from the linear trends expected from diffusion alone as a 
result of vertex-to-vertex hopping induced by user-controlled magnetic fields. Panels A, B, 
and C correspond to analysis of Figure 13C, D, and E, respectively. (A) Simultaneous 
transport of protein and DNA assemblies (upper and lower panels) is indicated by 
deviations from linear MSD (arrows). (B) Sequential magnetic transport of protein 
assemblies in the presence of DNA assemblies that are not transported is indicated by 
deviations from linear MSD in the red (upper), but not green (lower) panels. (C) However, 
when complementary SPIONs are added to green assemblies (lower panel), deviations are 
restored. Schematic (upper panel) in (C) depicts the process of sequential separation of 
protein and DNA assemblies. 
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In addition to simultaneous transport, specific molecules can also be separated from each 
other. The feasibility of multiplexed separation with simultaneous visualization was 
confirmed by separating protein and DNA on the same platform. Here, nanoassemblies 
were sequentially separated using the micro-patterned magnet array (zigzag wire 
formation) following addition of the complementary SPION-micelle conjugate (i.e., 
biotinylated-SPION micelles for avidin protein and p53 ssDNA-SPION micelles for p53 
DNA). After a short incubation period (~10-30 min), red QD-avidin-SPION 
nanoassemblies were transported across a distance of 20 µm via investigator-controlled 
vertex-to-vertex hopping, whereas green QD-p53 DNA-nanoassemblies (containing no 
magnetic SPION component) remained near their original location, as their motion was 
subject only to thermal fluctuations, and not magnetic forces from the wires (Figure 13D, 
Figure 14B, Appendix E Supplementary Video 4).  
Some movement resulting from Brownian motion and occasional liquid flow was observed 
in green p53 DNA composites, which was clearly distinguishable from vertex-to-vertex 
hopping. Vertex-to-vertex movement by user-controlled magnetic fields was differentiated 
from movement by diffusion by plotting mean squared displacement (MSD) against time 
(Figure 14B). MSD vs. time behavior is linear for assemblies undergoing Brownian motion 
alone (Equation 4.1). In contrast, assemblies undergoing magnetic transport exhibited 
deviations from linearity during magnetic trapping events at wire vertices. Thus, the motion 
of assemblies containing only QDs could be clearly distinguished from the motion of 
assemblies containing both QDs and SPIONs. 
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Trapping and transport of the red QD-avidin-SPION nanoassemblies (and the lack of 
trapping and transport for the green assemblies) was confirmed using the color-coded 
fluorescence signals, suggesting feasibility of one-component separation from a mixed 
solution. An aqueous solution of p53 ssDNA-SPION-micelles was then added to create 
green QD-p53-SPION nanoassemblies. Following incubation (~10-30 min), these 
assemblies were transported similarly to avidin-assemblies using investigator-controlled 
vertex-to-vertex motion, (Figure 13C and E, Appendix E Supplementary Video 5), thus 
demonstrating feasibility of separation of different molecules/assemblies from the same 
solution. Whereas a number of competing technologies also use color-coded signals to 
identify many different molecules (e.g., Nanostring106 or Western blots), this approach has 
the ability to identify and selectively transport and separate different molecules/assemblies. 
This result is enabled by the sandwich structure (Figure 10) employed for fluorescent-
magnetic nanocomposite formation, which takes advantage of the specificity of 
biomolecular assemblies. Manipulation of analytes at lower concentrations may be feasible 
by increasing the magnetic strength of the particles.90 Further, detection speed (i.e., 20 min 
incubation time) could be reduced by increasing the excess concentration of micelles 
employed to accelerate binding kinetics. 
Conclusions 
In this proof of concept work, we demonstrated a magneto-fluorescent detection/ 
separation platform that (1) performs rapid, sensitive, and specific separation of DNA 
and/or protein from a 5 µl solution (Speed: Minutes, Limit of Detection: ~0.1 fM via 
fluorescence, < 0.1 nM via magnetic capture; Sensitivity: No signal for single and double 
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basepair DNA mutations), (2) continuously visualizes individual molecular separation 
trajectories, and (3) enables multiplexed imaging and separation of analytes. This approach 
thus permits hierarchical assembly of structures, with the ability to transport, manipulate, 
and capture those assemblies in an integrated, parallel, and multiplexed manner. In contrast 
to force microscopy approaches, individual components are combined using a 
programmable self-assembly method that does not require external intervention or 
sequential placement to generate higher-order structures. Thus, directional changes can be 
induced non-invasively. For future applications, these results should be validated in more 
complex media, using clinical samples and guidelines. This technology could also be 
enhanced by incorporation of microfluidics for more sophisticated control of flow on the 
magnetic arrays and to enable future integration with existing lab-on-a-chip technologies. 
Thus, this technology platform may enable new opportunities in nanoassembly, molecular 
separation and analysis, and biomolecular research. 
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Chapter 5. Compact Quantum Dot Surface Modification to Enable Emergent Behaviors 
in Quantum Dot-DNA composites 
This chapter describes the synthesis of compact quantum dot-DNA conjugates and proof-
of-concept experiments demonstrating their potential utility in biosensing applications. 
This study was funded by NSF DBI-1555470. The aqueous transfer and optimization of 
carbodiimide chemistry for this study was conducted by Dr. Abhilasha Dehankar and 
Thomas Porter. The click chemistry scheme for this study was devised by Thomas Porter. 
The fluorescence resonance energy transfer studies were performed by Dr. Abhilasha 
Dehankar and DNA origami conjugation was performed by Dr. Joshua Johnson. The first 
draft of this chapter was authored by Dr. Abhilasha Dehankar. Writing and figure 
production was done by Dr. Abhilasha Dehankar and edited by Thomas Porter. This 
chapter is published as a manuscript in Dehankar A*, Porter T*, Johnson JA, Castro CE, 
Winter JO, (Invited) “Compact Quantum Dot Surface Modification to Enable Emergent 
Behaviors in Quantum Dot-DNA composites.” J. Chem. Phys., 151(14) (2019).107 *equally 
contributing authors. 
Introduction 
Modification of quantum dots (QDs) with single-stranded deoxyribonucleic acid (ssDNA) 
oligonucleotides is critical to their use in many applications, such as microarray 
detection108, Förster resonance energy transfer (FRET)-based biosensing109, and bio-
imaging110. Additionally, the rise of DNA nanotechnology has enabled precise 
organization of inorganic nanoparticles (NPs), permitting next-generation optoelectronic 
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and photonic devices to be realized via exploitation of NP emergent behaviors.111 However, 
the requirements for QDs conjugated to ssDNA (i.e., ssDNA-QDs) often exceed those of 
other biological QD conjugates, including the need for stability in solutions of wide pH 
range and high ionic strength. In particular, conjugation to DNA origami nanostructures 
can require stability in solutions with 5-20 mM Mg2+ concentrations.112,113 Many 
applications also demand precise control over the number of ssDNAs conjugated, with 
some applications necessitating a single ssDNA per particle, whereas in other cases high 
degrees of multivalency are desired.114,115 For applications that focus on distance dependent 
emergent behaviors between QDs or other NPs, such as FRET116 or fluorescence 
quenching, all of this must be achieved while minimizing coating thickness. Thus, methods 
that enable precise control of ssDNA conjugation to compact QDs are needed to realize 
their full potential in a wide variety of fields ranging from biomedical imaging to photonics. 
 
Because high quality QDs are primarily manufactured in the organic phase, ssDNA 
modification approaches necessarily require solubilization in aqueous media. Methods to 
obtain ssDNA-QDs can be divided into three main approaches117,118: (i) ssDNA 
incorporation in the QD crystal lattice during synthesis, (ii) direct attachment of ssDNA to 
the QD surface, and (iii) covalent attachment of ssDNA to the functional groups of ligands 
on QD surfaces. However, these methods suffer from several limitations, such as requiring 
a large excess of expensive ssDNA119, lack of control over ssDNA density119, thick surface 
coatings that limit capability to achieve emergent interactions120, or loss of colloidal 
stability121,122. For example, the most common approach employed, which is also used in 
commercial products, consists of QD modification with a thick polymer coating that 
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intercalates with organic ligands on the QD surface; ssDNA attachment is achieved via low 
yield carbodiimide chemistry routes.123 These approaches may maintain QD colloidal and 
photo-stability, but at the expense of a thick (i.e., > 3 nm increase in radius) coating and 
low control over ssDNA density. 
 
Several methods have been introduced to address challenges in QD conjugation, many of 
which rely on the high affinity of cysteine groups for the QD surface.124,125 Recently, a 
cysteine-rich peptide, 𝛾-phytochelatin-3 (PC3), was demonstrated to provide a compact 
coating (i.e., ~0.8-0.9 nm increase in radius) for aqueous QDs.126 PC3 is applied through 
exchange with native organic ligands, and presents multiple functional groups (4 -COOH 
and 1- NH2 per chain) available for conjugation in its final form. PC3-QDs demonstrate 
strong stability across a wide pH range (i.e., pH 5-10) and at high ionic strength (i.e., up to 
1.5 M NaCl).126 These properties are enabled by the flat conformation adopted by PC3 
molecules, with multiple thiol bonds to the QD surface and preferable orientation of 
remaining –COOH and –NH2 functional groups outward toward the surrounding media. 
However, to the best of our knowledge, PC3-QDs have only been employed in streptavidin-
biotin conjugation schemes that generate large increases in composite thickness (i.e., ~6 
nm increase in radius). Whereas PC3 –COOH and –NH2 groups are readily incorporated 
into low yield (~ 30%) carbodiimide-based conjugation schemes123, PC3-QDs lack 
functional groups required to take advantage of emerging biorthogonal conjugation 
methods, especially alkyne-azide “click” reactions. Click chemistry approaches provide a 
reliable means to achieve stoichiometric conjugation as a result of highly selective and 
efficient cycloaddition under mild conditions.115 
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Here, we combined PC3 passivation methods with copper-free alkyne-azide click 
chemistry to yield compact QDs conjugated to ssDNAs with precision. As model systems, 
we employed CdSe/ZnS QDs, most commonly used for biomedical imaging, and poly-
thymine (poly-T) ssDNA sequences, which minimize non-specific interactions with 
ssDNA strands and the QD surface. We also extended this work to mixed base-pair (mbp) 
sequences. Photophysical properties and ssDNA conjugation efficiency were quantified 
using absorption and fluorescence spectroscopy. Then, we demonstrated ssDNA 
functionality using two model systems that require compact QDs as a result of distance 
dependent behaviors or steric limitations. First, we explored implementation of ssDNA-
QDs as energy donors to gold nanoparticles (AuNPs) modified with complementary 
ssDNA, a system that demands close interactions between both particles and precise 
ssDNA conjugation to form QD-AuNP dimers. Next, we templated ssDNA-QDs on DNA 
origami hinge platforms through site-specific self-assembly, a sterically more demanding 
application. These data demonstrate methods for ssDNA-QD conjugation that result in a 
compact final product with potential for controllable conjugation yield, providing a 
possible platform technology for DNA-based QD devices.113,119 
 
Materials and Methods 
Chemicals  
CdSe/ZnS QDs (catalog no. CZ540-10, CZ560-10, CZ600-10) were purchased from NN-
Labs, LLC. (Fayetteville, Arizona). Gold nanoparticles (AuNPs) (catalog no. GP01-15-20) 
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were purchased from NANOCS, LLC. (New York, NY). Phytochelatin-3 (PC3) was 
custom synthesized and purchased from LifeTein, LLC. (Hillsborough, New Jersey). Azide 
and thiol modified oligonucleotides (ssDNAs) with optional fluorophore modification for 
bioconjugation were custom-ordered from Integrated DNA Technologies (Coralville, IA) 
(see Table 3 for sequences). Sulfo-dibenzocyclooctyne amine (sDBCO) was purchased 
from Click Chemistry Tools, LLC (Scottsdale, AZ) (catalog no. 1227). 
 
QD Aqueous Transfer  
Aqueous QD transfer was conducted using the “loops-trains-tails” approach via 
modification of the process described by Xu et al.126 Briefly, manufacturer-supplied QDs 
in toluene were transferred to chloroform. QDs in toluene (2 µM, 113 µL) were precipitated 
using methanol (100 µL) and re-dispersed in chloroform (37.5 µL). Then, pyridine (187.5 
µL) was added to the freshly solvated QDs (6 µM), followed by chloroform evaporation 
by heating. This step exchanges some of the native octadecylamine ligands on QD surface 
with pyridine. As a precaution, QDs were then centrifuged (20817g, 1 min) to remove any 
aggregates. Negligible precipitation was observed. After centrifugation, the supernatant 
containing suspended QDs (~1 µM, 450 µL in pyridine) was mixed with PC3 (40 mg/mL, 
100 µL in DI water), which formed a single-phase solution. Immediately, ligand exchange 
with PC3 was triggered by increasing solution pH above 10 by addition of 
tetramethylammonium hydroxide (TMAOH) (25 wt% in MeOH, Millipore Sigma catalog 
No. 334901), leading to the precipitation of QDs in pyridine. The solution was quickly 
vortexed and then centrifuged to form a pellet. The pellet was dispersed in DI water and 
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dialyzed overnight against 1x phosphate buffered saline (PBS) (0.1 M NaH2PO4, 0.15 M 
NaCl, pH 7.2, ThermoFisher Scientific Cat# 28372) using a 20K molecular weight cut-off 
(MWCO) Slide-A-Lyzer Mini Dialysis Unit (Rockford, IL) to remove excess, unbound 
PC3. The dialyzed PC3-QD suspension was stored at 4°C until use. 
 
QD Oligonucleotide Conjugation 
Aqueous PC3-QDs were conjugated to oligonucleotides via click chemistry in two steps. 
First, PC3-QDs were conjugated to sDBCO using zero-length cross-linker carbodiimide 
chemistry. (Note: Carbodiimide chemistry has much higher yields for small molecules, 
such as the sDBCO molecules employed here, compared to ssDNA molecules most likely 
because of electrostatic and steric limitations. Also, sDBCO are inexpensive and can 
therefore be added in large excess.) Briefly, PC3-QDs were exchanged into 2-(N-
morpholino)ethanesulfonic acid (MES, ThermoFisher Scientific Cat # 28390) buffer (0.1 
M, pH 5) using a 7K MWCO Zeba spin column (Pierce, IL) according to manufacturer’s 
protocol. PC3-QDs (70 µL, 2.5 µM) in MES were mixed with large excess of 1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC, Thermo Fisher Scientific, catalog No. 
77149) and sulfo-N-hydroxysuccinimide (sulfo-NHS, Thermo Fisher Scientific, catalog 
No. 24525) (EDC:sulfo-NHS:QD = 50,000:50,000:1, final EDC and sulfo-NHS 
concentration = 100 mM) and incubated for 25 minutes. Next, activated QDs were 
exchanged into PBS (0.1 M, pH 7.2) using a 40K MWCO Zeba spin column and mixed 
with sulfo-DBCO (QD: sDBCO = 1: 5000) and vortexed for 4 hours at room temperature. 
Excess sDBCO was separated from sDBCO-QD conjugates using a 40K MWCO Zeba spin 
column equilibrated with PBS buffer (0.1 M, pH 7.2).  
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In the second step, azide-terminated oligonucleotides were conjugated to purified sDBCO-
QDs via strain-promoted alkyne-azide cycloaddition click reaction. sDBCO-QDs in PBS 
(1.5 µM QDs, determined using a Nanodrop 100 spectrophotometer) were mixed with 
azide-terminated oligonucleotides (QD:ssDNA = 1:30) and allowed to react overnight at 
37 °C. Unconjugated oligonucleotides were separated from ssDNA-QD conjugates using 
30kDa Amicon centrifugal filters (3 washes with 1x PBS at 7000 rcf, 3 minutes each). QD-
DNA conjugates were stored in 1x PBS buffer with 2 wt% dissolved polyethylene glycol 
20 kDa (PEG-20k, Millipore Sigma, Cat. # 95172) at 4°C until use. 
 
AuNP Oligonucleotide Conjugation 
AuNP quenchers were conjugated to thiol-terminated oligonucleotides using an 
instantaneous, low pH-assisted conjugation protocol.127 Thiol-modified oligonucleotides 
received in stable disulfide forms (100 µM, 50 µL) were first reduced by reaction with 20 
µL of freshly-prepared 0.5 M DTT solution in sodium phosphate buffer (0.5 M, pH 8.4) 
for 1 hour at room temperature. Reduced oligos were purified from DTT using a size 
exclusion chromatography column (GE NAP-10) according to the manufacturer’s protocol. 
The concentration of reduced oligos was determined by UV-vis spectroscopy by comparing 
their absorbance at 260 nm (ssDNA peak) with a standard curve. Then, AuNPs were mixed 
with reduced oligos (AuNP:oligo = 1:225) for 1 minute at room temperature. Next, citrate 
buffer (500 mM, pH 3) was added to a final citrate buffer concentration of 10 mM and 
allowed to react for 3 minutes. The solution was then purified from unconjugated, excess 
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ssDNA and exchanged into 1x PBS buffer using a 100 kDa Amicon centrifugal filter. The 
ssDNA-AuNP conjugates were stored in 1x PBS at 4°C until use.  
QD-DNA-AuNP composite formation 
QDs and AuNPs presenting complementary ssDNA (Table 3) were mixed in desired ratios 
in PBS with 2 wt% PEG-20k at a fixed QD concentration of 3 nM and allowed to self-
assemble overnight at 4°C. For control experiments, QDs and AuNPs presenting non-
complementary ssDNA were mixed following the same method. Both the samples were 
prepared using green QDs (i.e., CZ540) and 15 nm AuNPs at QD:AuNP molar ratios of 
2:1, a final QD concentration of 3 nM, and a PEG concentration of 2% w/v in physiological 
0.1 M phosphate buffer saline (PBS) at pH 7. Samples were stored overnight before 
fluorescence measurement.  
Table 3 QD and AuNP DNA Sequences Employed 
NP ssDNA 5’ Sequence 3’ 
QD T16 Azide (N3) TT TTT TTT TTT TTT TT  
QD T16-Cy5 Azide (N3) TT TTT TTT TTT TTT TT Cy5Sp 
QD 12mbp-Cy5 Azide (N3) GT GCA TGT AAC G Cy5Sp 
QD T10 Azide (N3) TT TTT TTT TT Cy5Sp 
AuNP A20 C6-thiol AA AAA AAA AAA AAA AAA AAA  
AuNP T14 C6-thiol TT TTT TTT TTT TTT  
 
QD-DNA origami conjugation 
Briefly, DNA origami hinges were assembled in a solution of 20 nM m13mp18 
bacteriophage scaffold DNA, 200 nM of each staple strand, 1 mM EDTA 
(Ethylenediaminetetraacetic acid), 5 mM NaCl (Sodium Chloride), 5 mM Tris 
(tris(hydroxymethyl)aminomethane), and 18 mM MgCl2 (Magnesium chloride) as 
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previously described.128 ssDNA-QDs dissolved in 12.5 mM MgCl2 were mixed with DNA 
origami hinges presenting complementary ssDNA on both arms at QD:Hinge ratios of 5:1 
and incubating at 55°C for 10 minutes before cooling to room temperature. QD-DNA 
origami hinge conjugates were purified by gel electrophoresis (i.e., 2% agarose, 0.5X (Tris, 
Boric acid, Ethylenediaminetetraacetic acid (EDTA), TBE), 11 mM MgCl2) before 
transmission electron microscopy (TEM) imaging.  
 
Absorbance 
Absorbance measurements were used to confirm conjugation and determine NP 
concentrations. Absorption spectra were collected using a Genesys 6 UV-Visible or 
Nanodrop 1000 spectrophotometer.  
 
Fluorescence 
Fluorescence analysis using a PTI QuantaMaster fluorometer was performed to calculate 
quantum yields (QY), monitor QD bioconjugation to dye-labeled molecules, and analyze 
fluorescence quenching between QDs and AuNPs. Quantum yield was calculated using the 
equation described in Ref. 129: 
Φ𝑄𝐷 = Φ𝑠𝑡 ×
𝐹𝑄𝐷
𝐹𝑠𝑡
×
𝑓𝑠𝑡(𝜆𝑒𝑥)
𝑓𝑄𝐷(𝜆𝑒𝑥)
×
𝜂𝑄𝐷
2
𝜂𝑠𝑡
2    Equation 5.1 
where, Φ𝑥, 𝐹𝑥, 𝑓𝑥(𝜆𝑒𝑥) and 𝜂𝑥 are the quantum yield, spectrally-integrated fluorescence 
flux, absorption factor, and refractive index of the medium, respectively, and subscripts 
QS and St refer to the QD sample and a standard (Rhodamine 6G, ThermoFisher Scientific, 
Cat. No.252433), respectively.  
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For experiments optimizing conjugation, NH2-terminated dye molecules were employed 
and successful conjugation was monitored by measuring the fluorescence spectra of 
samples after purification. The presence of both QD and dye fluorescence peaks indicated 
successful conjugate formation. Efficiency of ssDNA conjugation was monitored by 
employing dye-labeled ssDNA, such that the oligonucleotide sequence was sandwiched 
between the -NH2 group and the dye molecule (i.e., NH2-ssDNA-dye). Presence of both 
QD and dye fluorescence peaks in purified samples indicated successful reaction. For 
determining number of ssDNA conjugated per QD, dye-tagged ssDNA was also used. The 
intensity of QD and dye-ssDNA fluorescence peaks were compared to their respective 
standard curves to calculate the ratio of ssDNA per QD. All measurements were conducted 
at concentrations that provided measurable signal for both QDs as well as conjugated 
ssDNA-dye molecules (~150 nM).  
Fluorescence quenching between QD and AuNP pairs was analyzed by comparing the 
fluorescence of hybridized QD-AuNP complexes (complementary sequence) with the 
fluorescence of unhybridized QD/AuNP solutions (non-complementary sequence) at the 
same concentration in 2 wt. % PEG-20K at QD:AuNP ratio of 2:1 and at 3 nM ssDNA-
QD. PEG-20K molecules were included to enable depletion stabilization of complexes.  
Transmission electron microscopy (TEM) 
QDs, AuNPs, and corresponding conjugates were imaged using an FEI Tecnai G2 Bio 
Twin TEM. Aqueous samples were deposited on ultrathin carbon coated copper grids, 300 
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mesh (Ted Pella, Redding, CA). For imaging QD-DNA origami conjugates, TEM grids 
were negatively stained with 2% uranyl formate as previously described.130 
 
Gel electrophoresis 
Gel electrophoresis was performed to validate ssDNA conjugation and to determine its 
efficiency using Cy5 dye-tagged ssDNA. During gel electrophoresis, unpurified ssDNA-
QD samples (100 µM, 15 µL), ssDNA, and PC3-QDs were analyzed using a 2 wt% agarose 
gel prepared in TE buffer at 110 V for 45 minutes. After completion, QD and dye-tagged 
ssDNA fluorescence was assessed using an Imager-Typhoon Trio (GE Healthcare) scanner 
with the Cy2-FRET and Cy5 excitation settings, respectively. Gel images were analyzed 
using NIH ImageJ to determine QD and ssDNA locations in the gel. The gel analysis 
feature of ImageJ was used to measure the ratio of fluorescence from conjugated versus 
unconjugated ssDNA to calculate the conjugation efficiency (conj%). The amount of 
ssDNA per QD was then calculated by: 
𝑠𝑠𝐷𝑁𝐴
𝑄𝐷
= 𝑐𝑜𝑛𝑗% × (
𝑠𝑠𝐷𝑁𝐴 𝑎𝑑𝑑𝑒𝑑
𝑄𝐷 𝑎𝑑𝑑𝑒𝑑
)   Equation 5.2 
 
Results and Discussion 
Photophysical properties and yield of PC3-QDs following aqueous phase transfer 
The highest quality QDs are manufactured in the organic phase; thus, they must first be 
transferred into the aqueous phase prior to ssDNA conjugation. Here, PC3 ligands were 
used to solubilize QDs because they exhibit numerous sulfur groups that form strong 
multidentate linkages to the QD surface and outward-facing -COOH and –NH2 functional 
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groups that increase the colloidal stability through electrostatic repulsion and provide sites 
for ssDNA attachment.126 Successful PC3 coating and QD phase transfer was performed 
using a modified version of the method described by Xu et al.126 in which QDs were not 
precipitated before dissolution in pyridine, reducing QDs losses resulting from this step 
(see Appendix D). With this modified approach, nearly 100% phase-transfer yield was 
observed.  
In contrast to prior reports126, PC3-QDs exhibited a small red-shift in peak emission 
wavelength (𝜆𝑒𝑚) (~ few nm) after the transfer process (Figure 15, Table 4), which was 
more pronounced for smaller QDs than larger ones (i.e., 𝜆540 > 𝜆560 > 𝜆600). Size-
dependent differences most likely reflect the reduced stability of smaller QDs, which have 
greater surface to volume ratio. Differences with respect to prior reports likely result from 
the native surface ligands employed: octadecylamine (ODA) in the current study versus 
trioctylphosphine oxide (TOPO).126 Primary amine ligands, such as ODA, exert 
compressive stress on the QD lattice in contrast to TOPO, which exerts a tensile stress.131 
The compressive stress of ODA is also responsible for the high QY of ODA-coated QDs. 
As a result, ligand exchange of ODA with PC3 may be accompanied by stretching of the 
QD lattice, effectively increasing the size of PC3-QDs and yielding a red-shift in emission 
wavelength. As is typical of aqueous phase transfer processes, QY was also reduced from 
that observed for organic QDs (Table 4) and was slightly lower than that reported for 
TOPO-capped QDs transferred via PC3 (i.e., 47%), most likely as a result of released 
lattice strain. 
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Figure 15 Absorbance and fluorescence spectra of QDs (green: λem = 540 nm, orange: λem 
= 560 nm, and red: λem = 600 nm) before (solid) and after (--) transfer to aqueous phase via 
PC3 ligand exchange. Note: Absorbance is only provided for samples prior to PC3 
exchange because of PC3 signal interference. 
 
 
 
 
Table 4 Photophysical properties of QDs before and after aqueous transfer 
Color 
𝜆𝑒𝑥 
(nm) 
𝜆𝑒𝑚(organic) 
(nm) 
QY% (organic) 
𝜆𝑒𝑚(aqueous) 
(nm) 
QY% (aqueous) 
Green 540 559 78 563 17 
Orange 560 581 70 583 20 
Red 600 618 69 617 32 
113 
 
 
 
ssDNA Conjugation to PC3-QDs using Click Chemistry 
Initially, we attempted to conjugate ssDNA molecules to PC3-QDs using carbodiimide 
chemistry as described previously for streptavidin conjugation126; however, we were 
unsuccessful (Figure 33, and Table 6). Thus, we adopted a click chemistry approach. 
However, PC3-QDs inherently lack alkyne or azide groups necessary for this reaction. 
PC3-QDs display two functionalities, -NH2 and -COOH groups, that could be used to add 
“click”-able groups via homo-bifunctional NHS-ester or carbodiimide zero-length 
crosslinker chemistries, respectively.132 However, the wide availability of azide-terminated 
oligonucleotides and greater number of -COOH groups on PC3-QDs strongly favors their 
use for alkyne modification.  
Thus, PC3 –COOH groups were first modified with sDBCO using carbodiimide chemistry 
(Figure 16), which is much more efficient for small molecules than the ssDNAs previously 
attempted. QD colloidal stability was enhanced by use of sDBCO instead of DBCO, and 
PEG -20k enabled depletion stabilization (Figure 34). This approach overcomes limitations 
of carbodiimide conjugation processes by enabling rigid and selective conjugation 
pathways in the latter part of the nested conjugation. Bio-orthogonal chemistry, 
specifically, click chemistry, proceeds via an alkyne-azide cycloaddition reaction that has 
been demonstrated to be highly reproducible and efficient under mild reaction 
conditions.115 Further, unlike the carbodiimide chemistry, click chemistry enables specific 
reaction between alkyne-azide groups without side-reactions, such as hydrolysis seen in 
carbodiimide alternatives.133  
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Figure 16 Absorbance spectra of PC3-QDs (solid) and sDBCO-PC3-QDs (--) formed via 
carbodiimide chemistry. sDBCO peak = ~260 nm. 
To generate ssDNA-QD conjugates, sDBCO-QDs were reacted with N3-terminated 
ssDNA. Reaction progress was monitored using ssDNAs modified with both N3 and Cy5 
fluorophores (Table 3). Fluorescence peaks for both QDs and Cy5 dye were observed in 
purified conjugates, indicating successful reaction (Figure 17a), which was further 
confirmed by gel electrophoresis (Figure 17b, c) (Note: The mobility difference of free 
Cy5-ssDNA in ssDNA and ssDNA-QD (U) lanes likely results from differences in buffer 
conditions during gel electrophoresis, as has previously been observed for ssDNA 
strands134). Fluorescence and gel electrophoresis analysis indicated a density of ~0.5 
ssDNA per QD using this approach; thus, some QDs were devoid of ssDNA. This may 
result from inconsistencies inherent in the “shotgun” carbodiimide chemistry employed in 
sDBCO attachment. With a target of ~ 1 ssDNA per QD desired to achieve dimerization 
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with AuNPs and avoid uncontrolled assembly, this was a satisfactory result. This procedure 
was used to reproducibly conjugate ssDNA to QDs of different sizes (i.e., 𝜆540 or 𝜆600) 
and with ssDNAs of different lengths (i.e., 10, 12, 16 bp) and sequences (i.e., mbp or poly-
T), indicating its robustness (Figure 35, Figure 36). 
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Figure 17 (a) Fluorescence spectra of ssDNA-QDs formed via click chemistry. ssDNA is 
functionalized with a Cy5 fluorophore for detection. (QDs: λex = 350 nm, λem = 561 nm; 
Cy5-ssDNA: λex = 649 nm, λem = 664 nm). Electrophoretic characterization of ssDNA-QD 
conjugates imaging using the (b) QD excitation wavelength (i.e., Cy2-Cy3-FRET setting 
on typhoon scanner) and (c) Cy5-ssDNA excitation wavelength (i.e., Cy5 setting on 
typhoon scanner). The large dashed boxes in (b) and (c) indicate the same gel location. U 
= Unpurified ssDNA-QD conjugates, P = Centrifugal filter purified ssDNA-QD 
conjugates. (Note: A spacer lane was introduced to avoid overlap of ssDNA signal from 
the free ssDNA, lane 2, and unpurified ssDNA-QDs, lane 4.) 
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ssDNA-QDs as Fluorescence Donors 
To evaluate the effectiveness of ssDNA-QDs, we next evaluated them in a fluorescence 
quenching application. In close-proximity to AuNPs, near-field effects emerge that modify 
QD fluorescence through static or dynamic charge or energy transfer135, FRET136, surface 
field enhancement137, or nanometal surface energy transfer (NSET)111,116. Near-field 
effects are extremely sensitive to interparticle spacing and decay as a function of 1/sn (𝑛 ≥
1). DNA offers tremendous potential to finely, reversibly, and reproducibly tune QD 
devices for these applications. Further, unlike many coatings used for QD aqueous 
solubilization120,138, the compact nature of the PC3 coating enables QDs to interface more 
intimately with the surrounding environment (i.e., within ~1 nm) while maintaining 
stability in physiological and high-salt conditions.  
Generally, changes in colloidal QD fluorescence in the presence of AuNPs can be broadly 
divided in two categories: (i) those arising from the inner-filter effect (IFE) and (ii) those 
arising from near-field effects.135 The IFE is an apparent decrease in fluorescence intensity 
resulting from attenuation of the excitation or emission beam at high concentration or in 
the presence of a highly absorbing material (e.g., AuNPs). Thus, the IFE effect results in a 
decrease in fluorescence intensity that is not a true quenching response and is not indicative 
of formation of DNA-hybridized NP pairs. The IFE can be empirically eliminated by 
decreasing sample OD < 0.05139; however, this was not possible here because decreasing 
the OD of the sample containing AuNPs < 0.05 resulted in QD fluorescence below the 
spectrophotometer detection limit. Alternatively, steady-state QD fluorescence can be 
monitored in the presence of AuNPs initially and as complexes form111,116. ssDNA-QDs 
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(T16-QD) were incubated with non-complementary ssDNA-AuNPs (T14-AuNPs), which 
should not form hybridized pairs (NC), and complementary ssDNA-AuNPs (A20-AuNPs) 
(C). Their fluorescence was compared (Figure 18), and the % decline of the entire sample 
was calculated as: 
% 𝑃𝐿𝑄𝑢𝑒𝑛𝑐ℎ = 1 −
𝐹𝐴𝑢𝑁𝑃−𝑐
𝐹𝐴𝑢𝑁𝑃−𝑛𝑐
      Equation 5.3 
where 𝐹𝐴𝑢𝑁𝑃−𝑐 and 𝐹𝐴𝑢𝑁𝑃−𝑛𝑐 are the steady-state peak fluorescence intensity of hybridized 
QD-AuNP composites and the non-complementary ssDNA- QD and -AuNP mixture, 
respectively.  
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Figure 18 (a) Fluorescence spectra of samples containing non-complementary ssDNA-QDs 
and ssDNA-AuNPs (solid) and complementary ssDNA-QD and ssDNA-AuNP conjugates 
forming QD-DNA-AuNP composites, (b) Bar-plot of the non-complementary and 
complementary fluorescence peak intensities (560 nm) for N = 3 samples. 
 
A ~75% decline in fluorescence was observed for hybridized complementary samples 
compared to mixtures of QDs and AuNPs presenting non-complimentary ssDNA (Figure 
18). However, this observation alone does not necessarily correlate to the quenching per 
hybridized NP pair, as the solution likely consists of a mixture of free and modified QDs 
based on fluorescence and electrophoresis results of ssDNA/QD. Given these factors, the 
change in QD fluorescence attributable to hybridization with AuNPs (S) can be represented 
as follows135: 
𝐹𝑐 = 𝜒𝐴𝑢𝑁𝑃 ∙ 𝐹𝑛𝑐 ∙ 𝑆 + (1 − 𝜒𝐴𝑢𝑁𝑃)𝐹𝑛𝑐  Equation 5.4 
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𝑆 =  
𝐹𝑐−(1−𝜒𝐴𝑢𝑁𝑃)𝐹𝑛𝑐
𝜒𝐴𝑢𝑁𝑃∙𝐹𝑛𝑐
    Equation 5.5 
where 𝐹𝑐 and 𝐹𝑛𝑐 are the measured fluorescence of samples incubated with C and NC 
AuNPs, respectively, and 𝜒𝐴𝑢𝑁𝑃 is the fraction of AuNP-hybridized QDs.  
The latter was determined experimentally by centrifuging C and NC solutions and 
measuring supernatant fluorescence after removing the large, high-density AuNPs and 
their conjugates. 𝜒𝐴𝑢𝑁𝑃 is then equal to: 
𝐹𝑛𝑐
𝑠𝑢𝑝𝑒𝑟
−𝐹𝑐
𝑠𝑢𝑝𝑒𝑟
𝐹𝑛𝑐
𝑠𝑢𝑝𝑒𝑟 . The first term of Equation 5.4 
denotes the contribution of hybridized composites to the fluorescence signal, whereas the 
second term denotes the contribution of free, non-hybridized QDs. Based on this analysis 
(Table 5), ~84% of the QDs in the solution formed hybridized AuNP-QD pairs, resulting 
in a near-field effect of 0.11 and an effective quenching of ~ 89.3% per QD, calculated as: 
100(1 − 𝑆). 
Table 5 FRET in QD-DNA-AuNP composites 
Sample % Floss, Bulk % hybridized S % Floss, S 
QD-16(AT)DNA-AuNP 75.0 0.84 0.11 89.3 
F = fluorescence, S = near field effect in AuNP-hybridized QDs, % Floss, Bulk is percent 
loss in fluorescence of the entire sample consisting of AuNP-hybridized and free QDs, % 
Floss, S is the percent of fluorescence loss resulting from near field effects in AuNP-
hybridized QDs. 
 
This analysis suggest that near field effects are the dominant cause of fluorescence loss in 
C solutions. Further, these results most likely originate from energy transfer between NPs. 
It has been previously demonstrated that static or dynamic charge or energy transfer, 
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surface field enhancement, and NSET are negligible at low concentrations135, for AuNPs 
 30 nm in diameter140, and for small polarizability differences for fluorophore-quencher 
pairs4, respectively. Thus, the most likely explanation for reduced fluorescence intensity 
via near field mechanisms is enhanced fluorescence quenching resulting from the 
significant spectral overlap between the emission of green QDs and AuNP absorbance and 
the reduced separation distance achieved by DNA hybridization141. At the QD:AuNP ratio 
(2:1) employed, quenching efficiency was significantly greater than that reported in studies 
using organic dye quenchers (i.e., < 30% at donor:acceptor ratios of 1:1) because of the 
high absorption cross-section of AuNPs.84,142 Comparable quenching efficiencies can still 
be achieved using organic quenchers by placing them very close to the QD surface143; 
however, such systems suffer from poor performance because of photobleaching. Further, 
the quenching efficiency observed here was also greater than that reported for many 
previous QD-AuNP systems144, most likely as a result of reduced inter-NP spacing enabled 
by DNA hybridization versus the use of large biomolecules (i.e., proteases) or because of 
low spectral overlap in those systems. Further, the current system displayed comparable or 
even slightly higher quenching efficiency than QD-ssDNA-AuNP systems with similar 
spectral overlap, despite increased ssDNA chain length (i.e., 16 base pairs (bp) in the 
current system versus 7-10 bp in prior reports116,145). This difference can be attributed to 
the thinner coating provided by PC3 on the QD surface that reduces inter-NP spacing.  
Nevertheless, quenching efficiency was lower than theoretical; ~99% efficiency would be 
expected for the QDs and AuNPs used in this system (i.e., See Appendix D calculations 
for details: absorbance spectral overlap = 1.34 ×  1019 M-1cm-1nm4, interparticle 
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spacing(s) = 6.7 nm (calculated based on DNA chain length), Förster radius (Ro) = 16.6 
nm). This may be explained by quenching efficiency dependence on donor valency (n), 
i.e., number of donors per quencher146: 
𝑆𝐹𝑅𝐸𝑇 = 
𝑛𝑅𝑜
6
𝑛𝑅𝑜
6+𝑠6
  Equation 5.6 
where 𝑆𝐹𝑅𝐸𝑇 and Ro are the quenching efficiency and Förster radius, respectively.  
The current system presents variable valency (i.e., some QDs do not contain ssDNA) 
because of differences in ssDNA number per QD. Although most QDs formed hybridized 
pairs with AuNPs, which were in excess, 16% failed to do so. Improved control over 
ssDNA conjugation through further optimization of click-based approaches would improve 
these results. Similarly, the centrifugal filtration purification approach employed here only 
separates free ssDNA from conjugates, not unmodified QDs, which we confirm to be 
present in solution based on fluorescence and electrophoresis results. Thus, these results 
could be improved by alternative separation schemes that enhance purification. 
Nonetheless, these data show that compact coating methods, such as those provided by 
PC3, combined with click chemistry-enabled ssDNA modification provide a robust 
approach for QD energy transfer materials. 
 
ssDNA-QD attachment and templating on DNA origami materials 
Next, we examined the ability of ssDNA QDs to be integrated with DNA origami materials. 
DNA origami can serve as a scaffold to precisely assemble NPs into complex 3D 
arrangements for potential applications in energy and photonics.147 However, most DNA 
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origami studies using NPs have been limited to AuNPs147, most likely because of their ease 
of ssDNA modification and stability at high ionic strength conditions (i.e., 5-20 mM 
divalent Mg) required to stabilize origamis.112 Few reports demonstrate QD attachment to 
DNA origami119,148, despite their obvious potential in opto-electrical devices. Some of 
these studies employ thick streptavidin coatings for composite formation that strongly limit 
distance-dependent emergent interactions between NPs and fail to provide the highly-
specific programmability achievable via DNA hybridization148. Thus, as a second model 
system, we evaluated ability of compact ssDNA-QDs to hybridize with sterically complex 
DNA origami platforms. 
In these experiments, ssDNA-QDs were incubated with DNA origami hinges128 that have 
previously been used for AuNP templating149 with binding sites (complementary 
overhangs) on the top and bottom arms (Figure 19a). QDs integrated with these platforms, 
as indicated by their position between hinge vertex arms in TEM images (Figure 19b). In 
most cases, QD binding resulted in hinges changing to a closed configuration, indicating a 
single QD is bound to both hinge arms. Although in some cases, QDs were bound to only 
one hinge arm. This may result from only 1 ssDNA/QD, which would enable only one 
complementary DNA pair to form. These data are similar to reports using the DNA 
embedding approach for QD templating on DNA origami platforms111,119; however, our 
method does not require a large excess of ssDNA for successful conjugation because of the 
specificity of click chemistry reactions. Combined with compact PC3 coatings that 
augment NP emergent interactions through reduced separation distances, this approach 
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may provide a more feasible, less expensive route to macroscale materials with energy 
applications.  
 
Figure 19 (a) Schematic of DNA origami hinges indicating locations of ssDNA overhangs 
on the top and bottom hinge arms for complementary ssDNA-QD binding. (b) TEM image 
of ssDNA-QD-DNA origami composites formed via hybridization with complementary 
ssDNA overhangs at distal locations on the top and bottom hinge arms (Inset scale: 100 
nm). 
Conclusions 
Here, we present a novel method for conjugation of ssDNA to QDs that combines a 
compact, multivalent coating methodology with mild, strain-promoted alkyne-azide 
cycloaddition click reactions to yield stable conjugates at high yield. This approach 
enhances potential for emergent interactions between QDs by reducing the thickness of 
coatings required to transfer QDs to the aqueous phase, while minimizing loss of 
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fluorescence and colloidal stability. Additionally, this method provides an alternative to 
popular carbodiimide chemistry approaches that are inefficient and non-specific, 
particularly when large, monovalent, charged molecules (e.g., ssDNA) are employed. 
Successful conjugation was confirmed by evaluating ssDNA hybridization in two 
platforms: fluorescence quenching with AuNP conjugates and conjugation to DNA origami 
materials. The resulting compact ssDNA-QDs hybridized with complementary ssDNA-
AuNPs (2:1 QD:AuNP ratio) resulting in 84% hybridized pairs and a quenching efficiency 
of 89% per hybridized pair. Further, enhanced colloidal stability of ssDNA-QDs enabled 
ready incorporation with DNA origami templating platforms despite the requirement of 
high ionic strength buffers to stabilize these systems. Improved control of conjugation 
reactions and subsequent separation steps would enhance these methods, enabling 
modification with specified numbers of DNA strands for highly controlled reaction. These 
results demonstrate ssDNA-PC3-QDs generated using click chemistry approaches as 
strong candidates for applications that leverage emergent NP interactions, such as FRET 
and optoelectronic devices. 
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Chapter 6. Conclusions and Future Directions 
Conclusions 
Overall, these studies identified and addressed several major considerations that must be 
made when developing QDs for biosensing applications, covering alternative nontoxic 
materials for QD synthesis, the effect of preparation steps on fluorescence properties, a 
QD-based sensing and manipulation platform, and a novel bioconjugation strategy for QD-
ssDNA conjugates. In the toxicity studies of Chapter 2, the toxicity of Mn-doped ZnSe 
QDs water solubilized via ligand exchange or micelle encapsulation was compared to the 
toxicity of CdSe/ZnS QDs water solubilized via the same methods in liver cancer cells. 
Overall, both samples of Mn-doped ZnSe QDs, as well as the micelle encapsulated 
CdSe/ZnS QDs were found to be non-toxic. This study demonstrated that micelle 
encapsulation may be a better alternative to ligand exchange for studies where toxicity may 
be of concern, and also demonstrated the promise of Mn-doped ZnSe QDs for biological 
applications. 
In Chapter 3, the effects of common steps employed during QD bioconjugation on QD 
quantum yield were investigated. Centrifugal filtration and buffer exchange with a low pH 
buffer commonly used in bioconjugation protocols were the two steps that resulted in the 
most significant QD stability issues (either colloidal stability or photostability) for QDs 
from multiple vendors. This study indicates that QD supplier conditions and processing 
procedures need to be carefully considered when designing experiments with biological 
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labeling applications in mind, and that universal procedures in bioconjugation chemistries 
should not be blindly followed without understanding their effects on QD stability. 
The applicability of the unique optical properties of QDs were demonstrated in the QD-
magnetic nanoparticle detection platform described in Chapter 4. In this platform, magnetic 
and fluorescent nanoparticles were encapsulated in separate micelles and mixed with 
analytes to form a sandwich assay. The multiplexing capabilities of QDs were utilized to 
simultaneously observe DNA and protein analytes with red and green fluorescent QDs, 
respectively. Furthermore, QD photostability enabled real-time visualization of the 
movement and sequential separation of analytes from solution via the magnetic 
nanoparticles. By conjugating proteins and ssDNA molecules onto the nanoparticle-
containing micelle surfaces, this self-assembly based assay achieved molecular-level 
detection and separations. 
Finally, in Chapter 5, a novel QD-DNA conjugation scheme was described. QDs with thin 
surface coatings were used in this study, facilitating their application in fluorescence 
resonance energy transfer-based sensing assays. These QDs demonstrated superior energy 
transfer compared to similar energy transfer systems involving QDs. Additionally, the 
broad utility of DNA as a building block nanomaterial was demonstrated by incorporating 
these QDs into DNA origami hinges. 
Future Directions 
Focusing on the QD conjugates discussed in Chapter 5, the broad flexibility of DNA 
nanomaterials opens avenues for several future directions. Regarding the QD-DNA 
conjugates themselves, improved conjugation steps may enable control over labeling 
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density (number of DNA strands per particle). In the methods described in Chapter 5, the 
QD-DNA conjugates averaged only ~1 DNA strand per particle. Whereas this is suitable 
for studies requiring monovalent binding of QDs, it is desirable to achieve a higher DNA 
labeling density for applications requiring multivalent binding of QDs. An example of 
when the former may be useful is an application involving fluorescence resonance energy 
transfer, where energy transfer efficiency is affected by the ratio of donors to quenchers. 
In this case, having only one binding site on the QD could make the analysis easier for a 
basic science study. On the other hand, an example of when the latter is useful could be a 
biosensing sandwich assay similar to the one described in Chapter 4, where additional 
binding sites on the QDs could provide higher detection sensitivity. To achieve better 
control over DNA conjugation to the QDs, it may be beneficial to employ a different click 
chemistry functional group than dibenzocyclooctyne-amine (DBCO). It was observed that 
QDs conjugated with DBCO were unstable because of the large hydrophobic moieties on 
DBCO (data not shown). As a result, QDs in this intermediate step often stick to the walls 
of their containers. Furthermore, the number of DBCO molecules that can be conjugated 
to a single QD is limited, as the QDs lose colloidal stability when their surface is saturated 
with the relatively hydrophobic DBCO molecules. As an alternative, it may be beneficial 
to conjugate an azide-containing molecule such as 3-azidoproplyamine or azido-PEG3-
amine, which does not contain such large hydrophobic groups. This would likely eliminate 
the issue of colloidal instability from oversaturating the QD surface and yield more 
consistent results. Then, reaction parameters could potentially be tuned to allow for control 
over DNA labeling density on the QDs. Furthermore, this reaction design is quite practical, 
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as DBCO-modified DNA is commercially available, as are the azide containing chemicals 
mentioned above. 
Beyond modifying the reaction parameters, additional functionality can be introduced to 
these QD conjugates using modified DNA. In particular, recent work in the Winter Lab has 
focused on the use of DNA with covalently linked photo-responsive azobenzene moieties. 
Light-responsive materials are desirable because they can be non-invasively manipulated 
without chemical contamination or heat input. Azobenzene undergoes isomerization 
between cis and trans conformations under different wavelengths of light irradiation. In its 
cis form (under ultraviolet irradiation, 300<λex<400 nm), azobenzene sterically hinders 
DNA duplex formation, thereby lowering the melting temperature (Tm) and preventing 
QDs from binding to other objects.150 In its trans form (under visible irradiation, λex>400 
nm), azobenzene stabilizes DNA duplexes through favorable stacking interactions, 
enabling QDs to bind other objects. Using gold nanoparticles (AuNPs) with 
complementary ssDNA as fluorescence quenchers (as described in Chapter 5), reversible 
quenching of QD fluorescence may be possible. The efficiency of this quenching effect is 
extremely sensitive to the interparticle distance, so modulating the excitation source to 
control DNA hybridization between the particles could be used to manipulate the energy 
transfer efficiency (Figure 20). 
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Figure 20 QD-AuNP photoswitchable probe design. 
 
 
Within this system, several opportunities for exploring the design space exist. For instance, 
DNA hybridization and dehybridization kinetics can be tuned by exploring the DNA 
sequence design. To achieve photoswitching at room temperature, DNA containing trans 
azobenzene should have Tm > room temperature, whereas DNA containing cis azobenzene 
should have Tm < room temperature. If photoswitching experiments are conducted in the 
same buffer conditions (e.g., phosphate buffered saline, pH=7.2), the Tm will depend most 
strongly on DNA sequence and length. However, the incorporation of azobenzene moieties 
into the DNA introduces several complexities that will need to be resolved. For instance, 
Liang et al. demonstrated that incorporating alternating azobenzene groups into each strand 
of the DNA yields a stable and symmetric DNA structure compared to having all 
azobenzene groups in one strand.151 By increasing the total number of azobenzene groups 
in a DNA strand of a given length, the difference in Tm between DNA containing cis and 
trans azobenzene groups increases. For further optimization, DNA sequence modifications 
of bases adjacent to the azobenzene groups may be adjusted. The cis to trans isomerization 
of azobenzene in DNA is believed to require free volume.152 By introducing base pair 
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mismatches and abasic sites adjacent to azobenzene groups, Yan et al. demonstrated 
increased azobenzene isomerization efficiency.153 By optimizing the DNA sequence 
design, the consistency of reversible photoswitching and quenching efficiency may be 
enhanced. In early studies in the Winter Lab, the DNA design with the greatest Tm 
difference from the study conducted by Liang et al. has been used to demonstrate reversible 
QD photoswitching (Figure 21).151 However, beyond demonstrating proof-of-concept, this 
system has yet to be explored and optimized. Interesting parameters to investigate could 
include quenching efficiency and the kinetics and number of photoswitching cycles 
achievable. 
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Figure 21 Demonstration of reversible photoswitching of QD-AuNP probes linked by 
complementary ssDNA containing azobenzene groups. (a) DNA sequence design 
(X=azobenzene). The top strand is conjugated to the QDs and the bottom strand is 
conjugated to the AuNPs. (b) UV excitation results in an “on” state in which the particles 
diffuse apart (blue), whereas visible excitation results in an “off” state where the particles 
are bound together (black). All three fluorescence spectra are from the same sample. The 
numbers in the legend correspond to the order in which measurements were taken. 
 
These photoswitchable QDs lend themselves to a vast range of potential applications. 
Within the Winter Lab, where biological imaging is a focus, these QDs could find use in 
super-resolution microscopy as part of an ongoing collaboration with The Kner Imaging 
Lab at the University of Georgia. Fluorescence microscopy is an immensely important tool 
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for elucidating the forms and functions of subcellular structures because of its labeling 
specificity and in vivo compatibility. However, fluorescence microscopy is limited in 
resolution. Two points that are close together (e.g., < ~500 nm) will appear as a single point 
because of light diffraction. One technique to overcome this limitation is stochastic optical 
reconstruction microscopy (STORM). STORM accomplishes single molecule localization 
by using photoswitchable probes that can be randomly turned on/off so that individual 
particles can be imaged exclusive of their nearest neighbors. Thousands of optically 
resolvable images with random on/off fluorophore cycles are reconstructed into a single 
image, enabling fluorophore positions to be determined with high precision, thereby 
increasing resolution.154 
An important factor in achieving high resolution in STORM is localization accuracy of the 
fluorescent probes, which is related to their rate of photon emission. The higher photon 
emission rate of QDs compared to typically employed molecular dyes can improve signal-
to-noise ratio. Additionally, QD resistance to photobleaching maximizes the total number 
of photons that can be collected, improving imaging resolution and speed. However, 
because QDs are not inherently photoswitchable, they have found limited application in 
super-resolution microscopy.  
Past approaches in utilizing QDs for single molecule localization microscopy have 
attempted to use QD blinking and photodegradation to achieve photoswitchability. QD 
blinking, random fluctuations in photoluminescence resulting from Auger recombination 
or hot electrons, achieves only limited contrast between “on” and “off” states, and therefore 
only limited improvements in resolution.155 In photodegradation based approaches, QDs 
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were photo-oxidized, resulting in shrinkage of the QD core. This caused a gradual blue 
shift in emission that eventually entered the range of a collection window. However, this 
method is restricted by the degradation rate of QDs and the number of photons collected in 
a blue-shifted collection window.61 It is therefore imperative to develop photoswitchable 
QDs that are more suitable for STORM. However, additional modifications would be 
necessary to facilitate these QDs use in imaging. For example, DNA-conjugated antibodies 
would be needed to give the QDs labeling specificity. Methods for cell entry would also 
be required, such as cell-penetrating peptides conjugated to the QD surface.156 
Overall, further development of these QD-DNA conjugates could enable exploration of 
novel cellular mechanisms, potentially impacting healthcare by improving our 
understanding of biology. Beyond imaging, several additional applications of these 
versatile QD-DNA conjugates can be envisioned. Other photo-responsive materials have 
found uses in a variety of applications including molecular logic gates, data recording and 
storage, multi-photon devices, and optoelectronics.157 In addition to conjugating these QDs 
with other nanoparticles, they may also be incorporated into DNA origami structures like 
those briefly discussed in Chapter 5 that enable elaborate three-dimensional spatial 
arrangements for investigating fundamental nanoscale physics.158 QDs have demonstrated 
immense potential for a broad range of applications owing to their unique size-dependent 
electronic and optical properties. Here, we showed initial steps toward the development of 
stimuli-responsive QDs for biological imaging and sensing applications. 
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Appendix A 
Chapter 2 Supplementary Information: Toxicity Assessment of Micelle encapsulated Mn-
doped ZnSe Quantum dots 
 Supplementary Figures 
Figure 22 MTT assay cell viability of PVA treated cells 
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Figure 23 MTT assay cell viability of empty micelle treated cells (the concentration 
represents the concentration of QDs that these micelles would encapsulate with the 
standard recipe) 
 
Figure 24 MTT assay cell viability of QD-micelle (concentrated) treated cells 
Chloroform concentration assay 
300 µl of the unknown sample or the standard calibration samples were mixed with 200 µl 
of 50% NaOH solution in a 1.5 ml centrifuge tube, followed by adding 250 µl of pyridine. 
Since PS-PEO has a much higher solubility in pyridine than in water, most of the polymers 
would be transferred into the pyridine phase, leaving no chloroform molecules trapped in 
the micelles. The mixture was then vortexed at 2000 rpm for 1 min, and incubated in 90°C 
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water bath for 2 min. The mixture was swiftly transferred to a cooling water bath to stop 
the reaction. Then, the vial was centrifuged briefly to cause water/pyridine phase 
separation, and 50 µl of pyridine was transferred to another vial. 150 µl of pyridine was 
added to the pyridine solution, and the solution was centrifuged at 20,000 rcf for 1 min. 
The supernatant was transparent with a pink to dark red color depending on the chloroform 
concentration in the sample. This supernatant solution has an absorbance peak at 540 nm, 
and the chloroform concentration is linearly proportional to the absorbance. 
Live-Dead flow-cytometry assay 
Live-Dead flow cytometry assay was performed with the LIVE/DEAD™ Cell Vitality 
Assay Kit, C12 Resazurin/SYTOX™ Green (L34951, Invitrogen). Briefly, cells were 
seeded in a 12 well plates at 80,000 cells per well with 3 replicas for each sample/control. 
After 24 h incubation, cell medium was removed from sample wells, and 1 mL of desired 
concentration nanoparticle solution was added to the plate and incubated with the cells for 
24 h. Next, the cells were harvested in a 15 mL centrifuge tube and washed with PBS to 
remove the NPs. Finally, washed cells at 1 x 106 cell/mL were treated with C12-resazurin 
(50 nM) and SYTOX Green (10 nM) stain for 15 minutes at 37°C. Cells were then analyzed 
by flow cytometry after dilution by exciting at 488 nm and measuring the fluorescence 
emission at 530 nm and 585 nm. The Live stain, C12-resazurin, changed structure in a 
metabolically active cell by reduction to generate red emission, whereas the green nucleic 
acid SYTOX stain only entered the nucleus of cells with damaged/compromised 
membranes observed in dead or injured cells. Flow-cytometry measures the fluorescence 
emission of each dye per cell. Thus, high red and low green emissions are observed in live 
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cells, high green and low red emission are observed in dead cells, and low red and green 
emissions are observed in unstained cells. The cells that display both stains at high-levels 
are considered injured cells that display lower metabolic activity and the beginnings of 
membrane destruction. 
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Appendix B 
Chapter 3 Supplementary Information: Fluorescence Loss of Commercial Aqueous 
Quantum Dots during Preparation for Bioimaging 
Supplementary Figures 
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Figure 25 (a) Photoluminescence QY wavelength dependence for QDs from 4 vendors 
excited at 488 nm and at the first exciton wavelength. (b) Excitation spectra for Rhodamine 
6G and QDs from 4 vendors. 
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Figure 26 Photoluminescence intensity (PL) and QY of QDs from Vendor 1 as a function 
of diluted concentration: (A) red QDs, Lot 2 and (B) green QDs. 
 
Figure 27 Photoluminescence (PL) intensity and QY of QDs from Vendor 1 after 
centrifugal filtration repeated up to 3 times (fixed concentration): (A) red QDs, lot 2, and 
(B) green QDs. 
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Figure 28 Representative images of QDs (0.1 µM) from Vendor #1 show substantial 
aggregation in pH 4.7, 0.1 M MES buffer. QDs from Vendor 1 (Lot 1) dispersed in (A) a 
compatible buffer (i.e., pH 9, 50 mM borate buffer) and (B) in an incompatible buffer (i.e., 
pH 4.7, 0.1 M MES buffer). QDs from Vendor #1, regardless of lot number or color, 
aggregated and precipitated in MES buffer. 
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Figure 29 QY of QDs from Vendor 1 (Lot 2) (0.1 µM), Vendor 2 (0.1 µM), and Vendor 3 
(0.15 µM) in pH 7.26 and pH 9, 50 mM borate buffer. 
 
 
158 
 
Appendix C 
Chapter 4 Supplementary Information: Biomolecular Detection, Tracking, and 
Manipulation using a Magnetic Nanoparticle-Quantum Dot Platform 
Supplementary Figures 
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Figure 30 Illustration of magnetic zigzag wire and disk patterns used in trapping 
experiments. For zigzag wires (A) and (B), magnetic domains form along wire segments 
(light gray arrows), resulting in locations of strong magnetic fields at wire vertices (blue 
arrows). These localized fields (and resulting field gradients) act as traps for magnetic 
nanoparticles. Upon applying a field ?⃗? 𝑧 perpendicular to the platform (indicated by black 
block arrows), the trap strength can be tuned. Relative trapping forces are indicated by the 
thickness of the blue arrows at wire vertices. (C) An in-plane applied field (?⃗? 𝑥𝑦) creates a 
magnetic domain in a disk and trapping locations at opposite edges of the disk. This domain 
can be rotated by rotating ?⃗? 𝑥𝑦. In the presence of an out-of-plane applied field ?⃗? 𝑧, the trap 
strengths can be tuned, as with the zigzag wires. (D) Schematic illustrating trapping and 
transport of micelle aggregates. 
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Figure 31 Typical electromagnet setup used for this experiment. Electromagnets produce 
in-plane magnetic field ?⃗? 𝑥𝑦 while the solenoid coil produces the out-of-plane field ?⃗? 𝑧. 
These fields are tunable by adjusting the current (and current direction) through the 
electromagnets or solenoid. 
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Figure 32 Single particle tracking (SPT) analysis of micelle “nanobrick” aggregate size 
(diameter) vs. total fluorescent intensity as measured by fluorescence microscopy. A 
positive correlation between fluorescent intensity and QD-micelle cluster diameter was 
evidenced. Because aggregate fluorescence intensity depends on the number of micelles in 
the aggregate, a volumetric, or 𝑟3, correlation between intensity and size would be 
expected. Also, particle sizes were clustered in the 10-100 nm range (inset), with few large 
aggregates formed. [Note, the fluorescence intensity here does not correspond with that of 
Figure 12, as different gains were used to capture larger aggregates. Fluorescence intensity 
is therefore reported in arbitrary units. For each experiment, QD micelles in the absence of 
analyte were first observed to obtain a baseline signal and aggregates were measured with 
reference to this baseline.] 
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Appendix D 
Chapter 5 Supplementary Information: Compact Quantum Dot Surface Modification to 
Enable Emergent Behaviors in Quantum Dot-DNA composites 
Supplementary Methods and Discussion 
PC3 Phase Transfer 
 
Initially, we followed the protocol of Xu et al. in which precipitation and re-dissolution of 
QDs in pyridine was employed.126 However, substantial losses were observed during phase 
transfer, attributed to incomplete dissolution of octadecylamine (ODA)-capped QDs in 
pyridine. ODA ligands have reduced affinity for pyridine compared to TOPO ligands 
originally employed in this protocol, which may hinder dissolution. The similarity of 
Hildebrandt solubility parameters (𝜹) for non-polar molecules is known to provide a 
reasonable estimate of their miscibility.159 In this case, calculated 𝜹 for TOPO (20 J1/2.cm-
3/2), ODA (15 J1/2.cm-3/2), and pyridine (22 J1/2.cm-3/2) indicate higher miscibility of TOPO 
compared to ODA in pyridine. Thus, higher losses can be attributed to reduced solubility 
of ODA-QDs in pyridine during phase transfer. These observations indicate the importance 
of establishing ligand-solvent compatibility in phase transfer processes. 
Carbodiimide Conjugation 
 
ssDNA conjugation to PC3-QD -COOH groups was attempted via carbodiimide chemistry, 
the most commonly employed approach. However, carbodiimide chemistries manifest 
poor conjugation efficiencies (< 30%) that are highly sensitive to reaction conditions, 
including concentration, time, pH, and ratio of NH2: COOH.
121,138,160 Therefore, reaction 
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conditions were first optimized using NH2-terminated cyanine-5 (Cy-5) dye molecules and 
then translated to NH2-terminated ssDNA molecules, which present larger steric and 
electrostatic considerations.  
PC3-QDs were exchanged into 2-(N-morpholino)ethanesulfonic acid (MES, ThermoFisher 
Scientific Cat # 28390) buffer (0.1 M, pH 5) using a 7K MWCO Zeba spin column (Pierce, 
IL) according to manufacturer’s protocol. PC3-QDs (70 µL, 2.5 µM) in MES were mixed 
with large excess of 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Thermo 
Fisher Scientific, catalog No. 77149) and sulfo-N-hydroxysuccinimide (sulfo-NHS, 
Thermo Fisher Scientific, catalog No. 24525) (EDC:sulfo-NHS:QD = 50,000:50,000:1, 
final EDC and sulfo-NHS concentration = 100 mM) and incubated for 25 minutes. Next, 
activated QDs were exchanged into PBS (0.1 M, pH 7.2) using a 40K MWCO Zeba spin 
column and mixed with NH2-terminated Cy-5 dye (Customized from IDT DNA 
Technologies) (QD:dye = 1: 5000) and vortexed for 4 hours at room temperature. Excess 
Cy-5 dye was separated from Cy-5-QD conjugates using a 40K MWCO Zeba spin column 
equilibrated with PBS buffer (0.1 M, pH 7.2).  
Although previous work reported successful conjugation of PC3-QDs to streptavidin126, 
NH2-terminated dye molecules failed to generate Cy-5-QD conjugates via the same 
protocol. This may be a consequence of the lower number of functional groups present in 
conjugates, just one for NH2-dyes versus many for streptavidin. To increase reaction 
efficiency, we increased either the number of NH2-terminated dye molecules (dye:QD ratio 
increased from 40:1 to 400:1) or the number of EDC molecules (EDC:QD increased from 
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3000:1 to 50000:1), achieving modest success via both approaches (Figure 33); however, 
the latter is less expensive and therefore preferred.  
 
Figure 33 Fluorescence spectra of purified Cy-5-QD conjugates formed via carbodiimide 
chemistry at EDC:QD= 50000 (λex: 580 nm; λem,QD: 615 nm, λem,ssDNA: 669 nm). 
 
Next, we optimized several conjugation parameters (Table 6), identifying optimal reaction 
conditions of QD activation pH 5, EDC: sulfo-NHS: QD Ratio = 50000:50000:1, activated 
QD reaction concentration (2 µM), carbodiimide reaction time of 4 hours and, target : QD 
ratio= 5000 (used in sDBCO-QD conjugation). This optimized protocol was used to 
conjugate ssDNAs to PC3-QDs. However, fluorescence peaks corresponding to cy-5-
ssDNA were not observed (not shown), indicating failure of the conjugation process. This 
may result from charge interactions. PC3 and ssDNAs can possess both positive and 
negative charges depending on pH, result from their -NH2 and -COOH groups and -NH2 
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and –PO4 groups, respectively138,160–162, although generally both molecules are negatively-
charged. Thus, charge repulsion between PC3 and ssDNA or even between ssDNAs163,164 
would be expected. Further, ssDNA molecules are much larger than dye molecules 
employed (although similar to or smaller than streptavidin molecules previously 
employed126), thus steric considerations may play a role as well. To address these concerns, 
PC3 -COOH and -NH2 groups were partially passivated with small poly(ethylene glycol) 
PEG molecules (MW = 2000, PEG-NH2: Fisher Scientific Cat# NC1462405 and PEG-
COOH: Cat# NC1504091) modified with -NH2 and -COOH groups, respectively using the 
optimized carbodiimide chemistry to block charge at PEG:QD ratios = 100), and solution 
ionic strength was increased to 0.15-1.2 M. However, these attempts were unsuccessful. 
 
Table 6 Carbodiimide reaction parameters optimized and effect on conjugation yield for 
the Cy-5 dye-NH2 PC3-QD system. 
Variable Range Effect on Conjugation Yield 
Activation pH 4.7-5  with  pH 
Reaction time 2-4 hrs  with  time  
QD concentration 0.75-2 µM  with  concentration  
EDC:sulfo-NHS:QD 
Ratio 
3000:3000:1 to 105:105:1  50000:50000:1 worked besta 
Dye:QD Ratio 15:1 to 500:1  with  ratio 
aPrecipitation was observed at the highest ratios (105:105:1). 
 
 
ssDNA Conjugation to PC3-QDs using Click Chemistry 
 
Initially, we attempted QD modification with dibenzocyclooctyne (DBCO), as reported 
previously165,166 (Figure 34); however, decreased colloidal stability, resulting in QD 
precipitation, was observed at high DBCO conjugation efficiency. This most likely 
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originated from the hydrophobic nature of DBCO functional groups. Thus, DBCO was 
replaced with sDBCO, which is charged and therefore more hydrophilic. However, 
although colloidal stability was improved, it was still lower than desired at high 
conjugation yields, possibly as a result of non-specific charge interactions arising from the 
charged sulfo- groups. Stability was easily restored by addition of high molecular weight 
PEG molecules (MW 20 kDa) that enabled long-range repulsive depletion stabilization.167 
Alternatively, stability could also be improved by decreasing the sDBCO:QD ratio or by 
replacing the alkyne functionality on QDs with N3. 
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Figure 34 Absorbance spectra of PC3-QDs (solid) and DBCO-PC3-QDs (--) formed via 
carbodiimide chemistry (DBCO peak = ~260 nm). 
 
Supplementary Calculations 
Theoretical quenching efficiency calculation 
 
Quenching efficiency (E) via FRET (i.e., Förster resonance energy transfer) mechanism 
was calculated as follows: 
𝑬 =  
𝑹𝒐
𝟔
𝒔𝟔+𝑹𝒐
𝟔   Equation D.1 
where 𝑹𝒐 is the Förster radius and d is the interparticle spacing. 
 𝑹𝒐 was calculated as follows: 
𝑹𝒐 = 𝟎. 𝟐𝟏𝟏 × [𝜿
𝟐∅𝑸𝑫𝜼
−𝟒𝑱(𝝀)]
𝟏
𝟔⁄   Equation D.2 
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where 𝜿𝟐 is relative orientation of transition dipoles of the donor and acceptor (assumed 
2/3 as an average of randomly fluctuating dipoles), ∅𝑸𝑫 is QD quantum yield (measured 
at 0.17 for QDs with 𝝀𝒆𝒎 = 𝟓𝟒𝟎 nm), 𝜼 is the medium refractive index (i.e., 1.33) and 
𝑱(𝝀) is the calculated spectral overlap integral of donor fluorescence spectra and acceptor 
absorbance spectra (𝟏. 𝟑𝟒 ×  𝟏𝟎𝟏𝟗 M-1.cm-1.nm4).168 The calculated 𝑹𝒐 was 16.6 nm. 
Interparticle spacing(s) was calculated as follows: 
𝒔 = 𝑳𝑫𝑵𝑨 + 𝑳𝑷𝑪𝟑 + 𝑳𝑪𝟔 Equation D.3 
where 𝑳𝑫𝑵𝑨 is the DNA length, (i.e., for 16 bp DNA, 𝟏𝟔 × 𝟎. 𝟑𝟑 𝒏𝒎 = 𝟓. 𝟑𝟑 𝒏𝒎), 𝑳𝑷𝑪𝟑 
is the thickness of the PC3 coating, 0.9 nm, and 𝑳𝑪𝟔 is the calculated size of the C6 linker, 
0.5 nm. Therefore, 𝒔 = 𝟔. 𝟕 𝒏𝒎. Plugging s and Ro into Equation 1 gives E = 0.99. 
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Additional Supplementary Figures 
 
Figure 35 Fluorescence spectra of ssDNA-QDs formed via click chemistry using red QDs 
(λem = 618 nm) and poly-T ssDNA of different lengths: T16 (solid) and T10 (grey). ssDNA 
was terminated with Cy-5 reporter dyes to enable detection. (λex = 580 nm, QDs: λem = 618 
nm, Cy5-ssDNA: λem = 664 nm). 
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Figure 36 Fluorescence spectra of ssDNA-QDs formed via click chemistry using green 
QDs (λem = 560 nm) and ssDNAs of different lengths and sequences: T16 (solid), T10 (grey) 
and 12mbp (grey-dashed). ssDNA was terminated with Cy-5 reporter dyes to enable 
detection. (QDs: λex = 350 nm, λem = 561 nm, Cy5-ssDNA: λex = 649 nm, λem = 664 nm). 
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Appendix E 
Chapter 4 Supplementary Videos: Biomolecular Detection, Tracking, and Manipulation 
using a Magnetic Nanoparticle-Quantum Dot Platform 
Supplementary Videos 
Supplementary videos are reproduced from K. D. Mahajan, G. Ruan, G. Vieira, T. Porter, 
J. J. Chalmers, R. Sooryakumar and J. O. Winter, J. Mater. Chem. B, 2020, Advance 
Article, https://doi.org/10.1039/C9TB02481F with permission from The Royal Society of 
Chemistry. The videos may be accessed using the following link: 
https://kb.osu.edu/handle/1811/91555. 
Descriptions: 
Supplementary Video 1: Nanoassembly transport around a microdisc. Control is 
demonstrated by magnetic trapping of the nanoassembly. A reverse motion around the disk 
is shown from 11-16 seconds, and then the particle continues its clockwise trajectory. After 
33 seconds the nanoassembly is released from the microdisc. 
Supplementary Video 2: Nanoassembly transport on nanowires via vertex-to-vertex 
hopping. 
Supplementary Video 3: Simultaneous magnetic transport of red protein (avidin) and 
green DNA (p53 ssDNA) nanoassemblies via vertex to vertex hopping on magnetic 
nanowire arrays. 
Supplementary Video 4: Red, magnetic protein nanoassemblies (i.e., avidin as the 
molecular target, containing SPIONs) are trapped and transported from vertex-to-vertex, 
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whereas green, non-magnetic DNA nanoassemblies (p53 ssDNA as the molecular target, 
containing no SPIONs) are not trapped and display motion resulting from Brownian motion 
or liquid flow. 
Supplementary Video 5: Following addition of DNA-targeting SPION micelles, green, 
magnetic DNA nanoassemblies (p53 ssDNA as the molecular target, containing QDs and 
SPIONs) are transported, showing rapid conjugation of SPIONs to green micelle structures. 
 
